Îñòàâüòå ññûëêó íà ýòó ñòðàíèöó â ñîöñåòÿõ:

Ïîèñê ïî áàçå äîêóìåíòîâ:

 

ÌÈÍÈÑÒÅÐÑÒÂÎ ÇÄÐÀÂÎÎÕÐÀÍÅÍÈß È ÌÅÄÈÖÈÍÑÊÎÉ ÏÐÎÌÛØËÅÍÍÎÑÒÈ

ÐÎÑÑÈÉÑÊÎÉ ÔÅÄÅÐÀÖÈÈ

 

ÁÞÐÎ ÏÎ ÐÅÃÈÑÒÐÀÖÈÈ ËÅÊÀÐÑÒÂÅÍÍÛÕ ÑÐÅÄÑÒÂ,

ÌÅÄÈÖÈÍÑÊÎÉ ÒÅÕÍÈÊÈ È ÈÇÄÅËÈÉ ÌÅÄÈÖÈÍÑÊÎÃÎ ÍÀÇÍÀ×ÅÍÈß

 

ÃÎÑÓÄÀÐÑÒÂÅÍÍÛÉ ÐÅÅÑÒÐ ËÅÊÀÐÑÒÂÅÍÍÛÕ ÑÐÅÄÑÒÂ

(Ïðîäîëæåíèå)

 

Ðàçäåë 2. ËÅÊÀÐÑÒÂÅÍÍÛÅ ÑÐÅÄÑÒÂÀ. (Ïðîäîëæåíèå)

 


 

┌──────────────────────────────────────────────────┬────────────────────────────────────────┬──────────────────────────────┬──────────────────────────────┬───────────────┐

│ Òîðãîâîå íàçâàíèå [ìåæä.íàçâàíèå] (Ñîñòàâ)          Ôàðì. ãðóïïà [Êîä ÀÒÑ]                    Ôîðìà âûïóñêà                   Ôèðìà (Ñòðàíà)         │ Íîìåð, Äàòà  

├──────────────────────────────────────────────────┼────────────────────────────────────────┼──────────────────────────────┼──────────────────────────────┼───────────────┤

│Ïàíãðîë 400 [Ïàíêðåàòèí] {ïðîòåàçà, àìèëàçà,      │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Berlin-Chemie AG (ÔÐÃ)        │003068,       

│ëèïàçà}                                           │[A09AA02]                               │îáîëî÷êîé                                                   │17.06.93      

                                                                                                                                                                    

│Ïàíçèíîðì {ëèïàçà 6000 ÌÅ, òðèïñèí 450 ÌÅ,        │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │äðàæå ôîðòå                   │Krka (Þãîñëàâèÿ)              │00359,        

│õèìîòðèïñèí 1500 ÌÅ, àìèëàçà 7500 ÌÅ, õîëåâàÿ     │[A09AC]                                                                                             │03.11.87,     

│êèñëîòà 0.0135 ã, ïåïñèí 50 ÌÅ, àìèíîêèñëîòû 0.1                                                                                                      │27.08.75      

│ã, ñîëÿíàÿ êèñëîòà 100 ìýêâ}                                                                                                                                         

                                                                                                                                                                    

│Ïàíêðàë {ïàíêðåàòèí 0.192 ã, ãåìèöåëëþëàçà 50 ìã, │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè                      │Dee-Pharma Ltd (Èíäèÿ)        │006562,       

│æåë÷è êîìïîíåíòû 25 ìã}                           │[A09AA02]                                                                                           │28.09.95      

                                                                                                                                                                    

│Ïàíêðåàòèí [Ïàíêðåàòèí] {ïðîòåàçà, àìèëàçà,       │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │äðàæå                         │ICN-Galenika (Þãîñëàâèÿ)      │007096,       

│ëèïàçà}                                           │[A09AA02]                                                                                           │21.02.96      

                                                                                                                                                                    

│Ïàíêðåàòèí [Ïàíêðåàòèí] {ïðîòåàçà, àìèëàçà,       │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè                      │Houhtamyaki Leiras Oy         │00653,        

│ëèïàçà}                                           │[A09AA02]                                                             │(Ôèíëÿíäèÿ)                   │06.11.90,     

                                                                                                                                                      │27.02.79      

                                                                                                                                                                    

│Ïàíêðåîí 10000 [Ïàíêðåàòèí] {ïðîòåàçà 550 ÌÅ,     │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Kali-Chemie Pharma GmbH       │007390,       

│àìèëàçà 8000 ÌÅ, ëèïàçà 10000 ÌÅ}                 │[A09AA02]                               │250 ìã                        │(Ãåðìàíèÿ)                    │02.04.96      

                                                                                                                                                                    

│Ïàíêðåîôëàò {ïàíêðåàòèí 170 ìã, äèìåòèêîí 80 ìã}  │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Kali-Chemie Pharma GmbH       │007572,       

                                                  │[A09AA02]                                                             │(Ãåðìàíèÿ)                    │11.06.96      

                                                                                                                                                                    

│Ïàíêóðìåí {ïàíêðåàòèí 35 ìã (àìèëàçà 1050 ÌÅ,     │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Berlin-Chemie Feb (ÃÄÐ)       │01501, 14.10.88│

│ëèïàçà 875 ÌÅ, ïðîòåàçà 63 ÌÅ), êóðêóìû êîðíåâèùà │[A09AA02]                               │îáîëî÷êîé                                                                 

│ýêñòðàêò 8.5 ìã}                                                                                                                                                    

                                                                                                                                                                    

│Ïàíîëåç {ëèïàçà 10 ÅÄ, àìèëàçà 10 ÅÄ, ïðîòåàçà 17 │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │äðàæå                         │Unichem Laboratories Ltd      │002722,       

│ÅÄ, æåë÷è êîìïîíåíòû 25 ìã, ãåìèöåëëþëàçà 50 ìã}  │[A09AA02]                                                             │(Èíäèÿ)                       │02.12.92      

                                                                                                                                                                    

│Ïàíñòàë {ëèïàçà 10 ÅÄ, àìèëàçà 10 ÅÄ, ïðîòåàçà 17 │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè                      │Wave International (Èíäèÿ)    │003996,       

│ÅÄ, æåë÷è êîìïîíåíòû 25 ìã, ãåìèöåëëþëàçà 50 ìã}  │[A09AA02]                                                                                           │14.06.94      

                                                                                                                                                                    

│Ïàíòåíîë [Äåêñïàíòåíîë]                           │ðåãåíåðàöèè ñòèìóëÿòîð [D03AX03]        │àýðîçîëü                      │Ankerpharm GmbH (Ãåðìàíèÿ)    │00481,        

                                                                                                                                                      │13.11.89,     

                                                                                                                                                      │14.12.94,     

                                                                                                                                                      │15.07.77      

                                                                                                                                                                    

│Ïàíòåíîë [Äåêñïàíòåíîë]                           │ðåãåíåðàöèè ñòèìóëÿòîð [A11HA30]        │òàáëåòêè 100 ìã; ðàñòâîð äëÿ  │Jenapharm (Ãåðìàíèÿ)          │00794,        

                                                                                          │èíúåêöèé (àìïóëû) 500 ìã - 2                                │15.09.80,     

                                                                                          │ìë                                                          │19.03.92      

                                                                                                                                                                    

│Ïàíòåíîëîâàÿ ìàçü [Äåêñïàíòåíîë]                  │ðåãåíåðàöèè ñòèìóëÿòîð [D03AX03]        │ìàçü 5%                       │CT-Arzneimittel Chemishe      │003968,        

                                                                                                                        │Tempelchof GmbH (Ãåðìàíèÿ)    │01.06.94      

                                                                                                                                                                    

│Ïàíòåòèí [Ïàíòåòèí]                               │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [A11HA32]   │òàáëåòêè 30, 60 ìã            │Daiichi Seiaku Pharmaceutical │00932, 03.08.82│

                                                                                                                        │Co Ltd (ßïîíèÿ)                             

                                                                                                                                                                    

│Ïàíöèòðàò [Ïàíêðåàòèí] {ëèïàçà, àìèëàçà, ïðîòåàçà}│ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │êàïñóëû ñ êèøå÷íîðàñòâîðèìûìè │Knoll AG (Ãåðìàíèÿ)           │003304,       

                                                  │[A09AA02]                               │ìèêðîòàáëåòêàìè 10000, 20000, │                              │08.09.93      

                                                                                          │25000 ÅÄ                                                                  

                                                                                                                                                                     

│Ïàïàâèí [Ïàïàâåðèí]                               │ñïàçìîëèòè÷åñêîå ñðåäñòâî [A03AD01]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Torrent Exports Ltd (Èíäèÿ)   │002762,       

                                                                                          │2 ìë                                                        │17.12.92      

                                                                                                                                                                    

│Ïàðà-ïëþñ {ïåðìåíòðèí 0.5%, ïèïåðîíèëà áóòèëàò    │ïðîòèâîïåäèêóëåçíîå ñðåäñòâî [P03AC04]  │àýðîçîëü äëÿ íàðóæíîãî        │S.C.A.T. (Ôðàíöèÿ)            │005047,       

│2%, ìàëàòèîí 0.25%}                                                                       │ïðèìåíåíèÿ                                                  │27.06.94      

                                                                                                                                                                    

│Ïàðàìîë [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Torrent Exports Ltd (Èíäèÿ)   │002670,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │27.10.92      

                                                                                                                                                                    

│Ïàðàïëàòèí [Êàðáîïëàòèí]                          │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA02]      │ðàñòâîð äëÿ èíúåêöèé          │Bristol-Myers Squibb (ÑØÀ)    │002363,       

                                                                                          │(ôëàêîíû) 50, 150, 450 ìã                                   │27.01.92      

                                                                                                                                                                    

│Ïàðàïëàòèí [Êàðáîïëàòèí]                          │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA02]      │ëèîôèëèç.ïîðîøîê äëÿ          │Bristol-Myers Squibb          │007031,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Ãåðìàíèÿ)                    │31.01.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) 50, 150,                                               

                                                                                          │450 ìã                                                                    

                                                                                                                                                                    

│Ïàðàöåò [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñèðîï (ôëàêîíû) 120 ìã|5 ìë - │Zdravle (Þãîñëàâèÿ)           │003654,       

                                                  │ñðåäñòâî [N02BE01]                      │100 ìë                                                      │31.01.94      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Aganall Traders Ltd (Èíäèÿ)   │002063,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │13.03.91      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ðàñòâîð îðàëüíûé (ôëàêîíû)    │Sanavita Gesundcheitsmittel & │005860,       

                                                  │ñðåäñòâî [N02BE01]                      │200 ìã|5 ìë                   │Co Kg (Ãåðìàíèÿ)              │23.03.95      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ìèêñòóðà                      │Berlin-Chemie AG (ÔÐÃ)        │02028, 13.12.90│

                                                  │ñðåäñòâî [N02BE01]                                                                                                

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñâå÷è 250 ìã                  │Berlin-Chemie AG (ÔÐÃ)        │002286,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │13.11.91      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Cadila Laboratories Ltd       │003003,       

                                                  │ñðåäñòâî [N02BE01]                                                    │(Èíäèÿ)                       │26.05.93      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Cox Pharmaceuticals           │003203,       

                                                  │ñðåäñòâî [N02BE01]                                                    │(Âåëèêîáðèòàíèÿ)              │09.08.93      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ñâå÷è 125,   │CT-Arzneimittel Chemishe      │005773,       

                                                  │ñðåäñòâî [N02BE01]                      │250, 500 ìã                   │Tempelchof GmbH (Ãåðìàíèÿ)    │24.02.95      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñèðîï (ôëàêîíû) 200 ìã - 5 ìë │CT-Arzneimittel Chemishe      │007436,       

                                                  │ñðåäñòâî [N02BE01]                                                    │Tempelchof GmbH (Ãåðìàíèÿ)    │15.04.96      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñèðîï                         │Dabur India Ltd (Èíäèÿ)       │002137,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │24.05.91      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │J.R.Sharma Overseas Ltd       │002062,       

                                                  │ñðåäñòâî [N02BE01]                                                    │(Èíäèÿ)                       │13.03.91       

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; òàáëåòêè     │Lyka Labs Ltd (Èíäèÿ)         │002260,       

                                                  │ñðåäñòâî [N02BE01]                      │ðàñòâîðèìûå 120 ìã                                          │17.10.91       

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ñèðîï        │Panacea Biotec Ltd (Èíäèÿ)    │003889,       

                                                  │ñðåäñòâî [N02BE01]                      │(ôëàêîíû) 125 ìã|5 ìë                                       │28.04.94      

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ðàñòâîð      │Pierre Fabre Medicament       │003466,       

                                                  │ñðåäñòâî [N02BE01]                      │îðàëüíûé äëÿ äåòåé (ôëàêîíû)  │(Ôðàíöèÿ)                     │28.10.93      

                                                                                          │3%                                                                        

                                                                                                                                                                    

│Ïàðàöåòàìîë [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Weimer Pharma GmbH (ÔÐÃ)      │003072,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │18.06.93      

                                                                                                                                                                    

│Ïàðàöåòàìîë 200 [Ïàðàöåòàìîë]                     │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ìèêñòóðà 200 ìã|5 ìë          │Berlin-Chemie AG (ÔÐÃ)        │003296,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │02.09.93      

                                                                                                                                                                    

│Ïàðàöåòàìîë 500 [Ïàðàöåòàìîë]                     │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Berlin-Chemie AG (Ãåðìàíèÿ)   │006792,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │03.11.95      

                                                                                                                                                                    

│Ïàðàöåòàìîë-Ðàòèîôàðì [Ïàðàöåòàìîë]               │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Ratiopharm GmbH & Co          │003458,       

                                                  │ñðåäñòâî [N02BE01]                                                    │(Ãåðìàíèÿ)                    │26.10.93      

                                                                                                                                                                    

│Ïàðàöåòàìîë-Ðàòèîôàðì [Ïàðàöåòàìîë]               │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñâå÷è äëÿ äåòåé 125 ìã        │Merckle GmbH (ÔÐÃ)            │002939,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │30.03.93      

                                                                                                                                                                    

│Ïàðàöåòàìîë-Ðèâîôàðì [Ïàðàöåòàìîë]                │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñèðîï 125 ìã|5 ìë             │Rivopharm SA (Øâåéöàðèÿ)      │005460,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │04.11.94      

                                                                                                                                                                    

│Ïàðæèí [Àðãèíèí]                                  │ãåïàòîïðîòåêòîð [A05BA01]               │ðàñòâîð îðàëüíûé (àìïóëû) 5   │Laboratoires Sarge (Ôðàíöèÿ)  │002191,       

                                                                                          │ìã - 10 ìë                                                  │08.07.91      

                                                                                                                                                                    

│Ïàðêîïàí 2 [Òðèãåêñèôåíèäèë]                      │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 2 ìã                 │Hexal Pharma GmbH (Ãåðìàíèÿ)  │007229,       

                                                  │[N04AA01]                                                                                           │26.06.96      

                                                                                                                                                                    

│Ïàðêîïàí 5 [Òðèãåêñèôåíèäèë]                      │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 5 ìã                 │Hexal Pharma GmbH (Ãåðìàíèÿ)  │007230,       

                                                  │[N04AA01]                                                                                           │26.06.96      

                                                                                                                                                                    

│Ïàðëîäåë [Áðîìîêðèïòèí]                           │äîôàìèí-ñòèìóëÿòîð [N04BC01]            │òàáëåòêè 2.5 ìã               │Sandoz Pharma (Øâåéöàðèÿ)     │00616,        

                                                                                                                                                      │08.09.78,     

                                                                                                                                                      │24.03.94      

                                                                                                                                                                    

│Ïàðëîäåë [Áðîìîêðèïòèí]                           │äîôàìèí-ñòèìóëÿòîð [N04BC01]            │òàáëåòêè 2.5 ìã               │Sandoz Urunleri Ilac (Òóðöèÿ) │005397,       

                                                                                                                                                      │14.10.94      

                                                                                                                                                                    

│Ïàðñåäèë [Äèïèðèäàìîë]                            │âàçîäèëàòèðóþùåå ñðåäñòâî [B01AC07]     │äðàæå 75 ìã                   │Alkaloid (Ìàêåäîíèÿ)          │005291,       

                                                                                                                                                      │05.09.94      

                                                                                                                                                                    

│Ïàðòóñèñòåí [Ôåíîòåðîë]                           │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 5 ìã; ðàñòâîð äëÿ    │Boehringer Ingelheim (ÔÐÃ)    │00700,        

                                                  │[G02CA03][R03CC04]                      │âíóòðèâåííîãî ââåäåíèÿ                                      │07.09.79,     

                                                                                          │(àìïóëû) 0.5 ìã - 10 ìë                                     │20.06.90      

                                                                                                                                                                    

│Ïàðòóñèñòåí èíòðàïàðòàëüíûé [Ôåíîòåðîë]           │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Boehringer Ingelheim          │003446,       

                                                  │[G02CA03]                               │èíúåêöèîííîãî ðàñòâîðà        │International GmbH (Ãåðìàíèÿ) │27.10.93      

                                                                                          │(ôëàêîíû) 25 ìêã/ìë                                                       

                                                                                                                                                                    

│Ïàñåìîë [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │Ipca Laboratories Ltd (Èíäèÿ) │003785,       

                                                  │ñðåäñòâî [N02BE01]                      │èíúåêöèé (àìïóëû) 150 ìã/1                                  │25.03.94       

                                                                                          │ìë; ñèðîï (ôëàêîíû) 125 ìã|5                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                     

│Ïàòåíòåêñ Îâàëü [Íîíîêñèíîë]                      │êîíòðàöåïòèâíîå ñðåäñòâî [G02BB]        │ñâå÷è âàãèíàëüíûå 75 ìã       │Merz Co GmbH (ÔÐÃ)            │003156,       

                                                                                                                                                      │19.07.93      

                                                                                                                                                                     

│Ïàöèìîë [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │Ipca Laboratories Ltd (Èíäèÿ) │006432,       

                                                  │ñðåäñòâî [N02BE01]                      │èíúåêöèé (àìïóëû) 150 ìã/1                                  │23.08.95      

                                                                                          │ìë; ñèðîï (ôëàêîíû) 125 ìã|5                                               

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ïåâàðèë [Ýêîíàçîë]                                │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC03]     │ëîñüîí 1%; êðåì 1%            │Cilag (Øâåéöàðèÿ)             │006602,       

                                                                                                                                                      │30.11.95      

                                                                                                                                                                    

│Ïåäèëèí [Ìàëàòèîí]                                │ïðîòèâîïåäèêóëåçíîå ñðåäñòâî [P03AX03]  │øàìïóíü; ýìóëüñèÿ             │Krka (Ñëîâåíèÿ)               │006358,       

                                                                                                                                                      │07.08.95      

                                                                                                                                                                    

│Ïåå Õîî {àëãåëäðàò 0.4 ã, ìàãíèÿ êàðáîíàò 0.4 ã,  │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè; ñóñïåíçèÿ           │Orion Pharmaceutica           │01209, 19.11.85│

│êàëüöèÿ êàðáîíàò 0.1 ã, ìàííèòîë 0.3 ã -                                                                                │(Ôèíëÿíäèÿ)                                 

│òàáëåòêà; àëãåëäðàò 63 ìã, ìàãíèÿ êàðáîíàò 63 ìã, │                                                                                                                  

│ìàãíèÿ ãèäðîêñèä 40 ìã, ñîðáèòîë 38.5 ìã - 1 ìë}                                                                                                                    

                                                                                                                                                                    

│Ïåå-Õîî {àëãåëäðàò 0.4 ã, ìàãíèÿ êàðáîíàò 0.4 ã,  │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè; ñóñïåíçèÿ îðàëüíàÿ  │Eczacibasi (Òóðöèÿ)           │002147,       

│êàëüöèÿ êàðáîíàò 0.1 ã, ìàííèòîë 0.3 ã -                                                                                                              │28.05.91      

│òàáëåòêà; àëãåëäðàò 63 ìã, ìàãíèÿ êàðáîíàò 63 ìã, │                                                                                                                  

│ìàãíèÿ ãèäðîêñèä 40 ìã, ñîðáèòîë 38.5 ìã - 1 ìë}                                                                                                                    

                                                                                                                                                                    

│Ïåêòèïðîíò [Áåíïðîïåðèí]                          │ïðîòèâîêàøëåâîå ñðåäñòâî [R05DB02]      │ñèðîï (ôëàêîíû) 300 ìã - 100  │Heinrich Mack Nachf.          │005268,       

                                                                                          │ìë                            │(Ãåðìàíèÿ)                    │22.08.94      

                                                                                                                                                                    

│Ïåëåíòàí [Ýòèë áèñêóìàöåòàò]                      │àíòèêîàãóëÿíò, âèòàìèíà Ê àíòàãîíèñò    │òàáëåòêè 300 ìã               │Spofa (×åõîñëîâàêèÿ)          │2259,         

                                                  │[B01AA08]                                                                                           │05.12.84,     

                                                                                                                                                      │29.07.71      

                                                                                                                                                                    

│Ïåëîêñ-400 [Ïåôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã; ðàñòâîð äëÿ  │Wockhardt Ltd (Èíäèÿ)         │007444,       

                                                  │[J01MA03]                               │âíóòðèâåííîãî ââåäåíèÿ                                      │17.04.96      

                                                                                          │(ôëàêîíû) 400 ìã - 100 ìë                                                 

                                                                                                                                                                    

│Ïåí-îñ [Ôåíîêñèìåòèëïåíèöèëëèí]                   │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Eczacibasi (Òóðöèÿ)           │003382,       

                                                                                          │1000000 ÅÄ                                                  │06.10.93      

                                                                                                                                                                    

│Ïåíáàê [Áàêàìïèöèëëèí]                            │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │òàáëåòêè 400 ìã               │Eczacibasi (Òóðöèÿ)           │005533,       

                                                  │[J01CA06]                                                                                           │01.12.94      

                                                                                                                                                                    

│Ïåíãëîá [Áàêàìïèöèëëèí]                           │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │òàáëåòêè 400, 800 ìã          │Astra (Øâåöèÿ)                │002440,       

                                                  │[J01CA06]                                                                                           │31.01.92      

                                                                                                                                                                    

│Ïåíèöèëëèí G íàòðèåâàÿ ñîëü [Áåíçèëïåíèöèëëèí]    │àíòèáèîòèê, ïåíèöèëëèí [J01CE01]        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Biochemie GmbH (Àâñòðèÿ)      │005198,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │01.08.94      

                                                                                          │(ôëàêîíû) 1000000, 5000000,                                               

                                                                                          │10000000 ÌÅ                                                               

                                                                                                                                                                    

│Ïåíèöèëëèí-Òåâà [Áåíçèëïåíèöèëëèí]                │àíòèáèîòèê, ïåíèöèëëèí [J01CE01]        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Teva Pharmaceutical           │006737,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Industries Ltd (Èçðàèëü)      │23.10.95      

                                                                                          │(ôëàêîíû) 1 ÌÅ, 5 ÌÅ, 10 ÌÅ                                               

                                                                                                                                                                    

│Ïåíèöèëëèí-Ôàó [Ôåíîêñèìåòèëïåíèöèëëèí]           │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │CT-Arzneimittel Chemishe      │003487,       

                                                                                          │1000000 ÅÄ                    │Tempelchof GmbH (Ãåðìàíèÿ)    │04.11.93       

                                                                                                                                                                    

│Ïåíîäèë [Àìïèöèëëèí]                              │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │êàïñóëû 250, 500 ìã           │Remedica Ltd - Minnex (Êèïð)  │006841,       

                                                  │[J01CA01]                                                                                           │17.11.95       

                                                                                                                                                                    

│Ïåíñåëèí [Äèïèðèäàìîë]                            │âàçîäèëàòèðóþùåå ñðåäñòâî [B01AC07]     │òàáëåòêè 25 ìã                │Sawai Pharmaceutical Co Ltd   │003154,       

                                                                                                                        │(ßïîíèÿ)                      │16.07.93      

                                                                                                                                                                    

│Ïåíòàãëîáèí [Èììóíîãëîáóëèí (â/â ââåäåíèå)]       │èììóíîñòèìóëÿòîð [J06BA02]              │ðàñòâîð äëÿ èíôóçèé (àìïóëû)  │Biotest Pharma GmbH (Ãåðìàíèÿ)│005797,       

                                                                                          │5% - 10, 20 ìë; ðàñòâîð äëÿ                                 │02.03.95      

                                                                                          │èíôóçèé (ôëàêîíû) 5% - 50,                                                

                                                                                          │100 ìë                                                                    

                                                                                                                                                                    

│Ïåíòàêàðä-10 [Èçîñîðáèä ìîíîíèòðàò]               │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 10 ìã                │Cedona Pharmaceutical         │003036,       

                                                                                                                        │(Íèäåðëàíäû)                  │07.06.93      

                                                                                                                                                                    

│Ïåíòàêàðä-20 [Èçîñîðáèä ìîíîíèòðàò]               │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20 ìã                │Cedona Pharmaceutical         │003036,       

                                                                                                                        │(Íèäåðëàíäû)                  │07.06.93      

                                                                                                                                                                    

│Ïåíòàêàðä-40 [Èçîñîðáèä ìîíîíèòðàò]               │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 40 ìã                │Cedona Pharmaceutical         │003036,       

                                                                                                                        │(Íèäåðëàíäû)                  │07.06.93      

                                                                                                                                                                    

│Ïåíòàêàðèíàò [Ïåíòàìèäèí]                         │ïðîòèâîëåéøìàíèîçíîå ñðåäñòâî [P01CX01] │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003392,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │08.10.93      

                                                                                          │(ôëàêîíû) 300 ìã; ïîðîøîê äëÿ │                                            

                                                                                          │ïðèãîòîâëåíèÿ èíãàëÿöèîííîãî                                              

                                                                                          │ðàñòâîðà (ôëàêîíû) 300 ìã                                                 

                                                                                                                                                                    

│Ïåíòàëîíã [Ïåíòàýðèòðèòèëà òåòðàíèòðàò]           │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA05]     │òàáëåòêè 50 ìã                │Isis Pharma GmbH (Ãåðìàíèÿ)   │005345,       

                                                                                                                                                      │21.09.94      

                                                                                                                                                                    

│Ïåíòàìîí [Ïåíòîêñèôèëëèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè 400 ìã               │Pliva SA (Õîðâàòèÿ)           │006074,       

                                                                                                                                                      │22.05.95      

                                                                                                                                                                    

│Ïåíòàðöèí [Àìïèöèëëèí]                            │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Polfa (ÏÍÐ)                   │2524, 10.06.77 │

                                                  │[J01CA01]                               │èíúåêöèîííîãî ðàñòâîðà 250,                                               

                                                                                          │500 ìã                                                                    

                                                                                                                                                                    

│Ïåíòèëèí [Ïåíòîêñèôèëëèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè 400 ìã; ðàñòâîð äëÿ  │Krka (Ñëîâåíèÿ)               │002596,       

                                                                                          │èíúåêöèé (àìïóëû) 100 ìã - 5                                │12.08.92      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ïåíòîãåêñàë [Ïåíòîêñèôèëëèí]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè ðåòàðä 600 ìã        │Hexal Pharma GmbH (Ãåðìàíèÿ)  │005142,       

                                                                                                                                                      │18.07.94      

                                                                                                                                                                    

│Ïåíòîêñ-400 [Ïåíòîêñèôèëëèí]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè 400 ìã               │International-Pharmaceuticals │005316,       

                                                                                                                        │(Èíäèÿ)                       │14.09.94      

                                                                                                                                                                    

│Ïåíòîêñèôèëëèí [Ïåíòîêñèôèëëèí]                   │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè 100, 400 ìã; ðàñòâîð │Wave International (Èíäèÿ)    │006298,       

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 300 ìã                                │18.07.95      

                                                                                          │- 15 ìë                                                                   

                                                                                                                                                                    

│Ïåíòîêñèôèëëèí-Ðàòèîôàðì [Ïåíòîêñèôèëëèí]         │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè ðåòàðä 400 ìã        │Ratiopharm GmbH & Co (ÔÐÃ)    │003216,       

                                                                                                                                                      │10.08.93      

                                                                                                                                                                    

│Ïåíòîìåð [Ïåíòîêñèôèëëèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè ðåòàðä 400 ìã;       │Ludwig Merckle GmbH (Àâñòðèÿ) │003027,       

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                              │01.06.93      

                                                                                          │100 ìã - 5 ìë; êîíöåíòðàò äëÿ │                                            

                                                                                          │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                                 

                                                                                          │ðàñòâîðà (àìïóëû) 300 ìã - 15 │                                            

                                                                                          │ìë                                                                        

                                                                                                                                                                     

│Ïåíòîìåð [Ïåíòîêñèôèëëèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Ludwig Merckle GmbH (Àâñòðèÿ) │005344,       

                                                                                          │îáîëî÷êîé ðåòàðä 600 ìã                                     │21.09.94      

                                                                                                                                                                     

│Ïåíòîòàë [Òèîïåíòàë íàòðèÿ]                       │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Abbott Laboratories (Èòàëèÿ)  │003695,       

                                                  │[N01AF03]                               │èíúåêöèîííîãî ðàñòâîðà                                      │15.02.94      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                         

                                                                                                                                                                    

│Ïåíòðåêñèë [Àìïèöèëëèí]                           │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Galenika (Þãîñëàâèÿ)          │00269,        

                                                  │[J01CA01]                               │èíúåêöèîííîãî ðàñòâîðà                                      │01.08.85,     

                                                                                          │(ôëàêîíû) 250, 500 ìã; êàïëè                                │14.01.74      

                                                                                          │äëÿ äåòåé (ôëàêîíû) 100 ìã/ìë │                                            

                                                                                          │- 20 ìë                                                                   

                                                                                                                                                                    

│Ïåíòðåêñèë [Àìïèöèëëèí]                           │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ñóñïåíçèÿ äëÿ äåòåé           │Galenika (Þãîñëàâèÿ)          │00613, 05.09.78│

                                                  │[J01CA01]                                                                                                         

                                                                                                                                                                    

│Ïåïëîöèí [Ïåôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Nippon Kayaku Co Ltd (ßïîíèÿ) │02046, 22.02.91│

                                                  │[J01MA03]                               │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 10 ìã                                                           

                                                                                                                                                                    

│Ïåïñèäèí [Ôàìîòèäèí]                              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 20, 40 ìã;           │Merck Sharp & Dohme           │005838,       

                                                  │[A02BA03]                               │ëèîôèëèç.ïîðîøîê äëÿ          │(Ãîëëàíäèÿ)                   │28.03.95      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 20 ìã;                                                 

                                                                                          │ðàïèäèñêè 20, 40 ìã                                                       

                                                                                                                                                                    

│Ïåïòîðàí [Ðàíèòèäèí]                              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150 ìã               │Pliva (Þãîñëàâèÿ)             │01315, 08.01.87│

                                                  │[A02BA02]                                                                                                         

                                                                                                                                                                    

│Ïåðãîãðèí [Ìåíîòðîïèí] {ôîëëèêóëîñòèìóëèðóþùèé    │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Serono Pharma Spa (Èòàëèÿ)    │005790,       

│ãîðìîí 75 ÌÅ, ëþòåèíèçèðóþùèé ãîðìîí 35 ÌÅ;       │[G03GA02]                               │ïðèãîòîâëåíèÿ âíóòðèìûøå÷íîãî │                              │27.02.95      

│ôîëëèêóëîñòèìóëèðóþùèé ãîðìîí 150 ÌÅ,                                                     │ðàñòâîðà (àìïóëû) /â                                                      

│ëþòåèíèçèðóþùèé ãîðìîí 70 ÌÅ}                                                             │êîìïëåêòå ñ ðàñòâîðèòåëåì/ 75 │                                            

                                                                                          │ÌÅ ÔÑÃ/35 ÌÅ ËÃ, 150 ÌÅ                                                   

                                                                                          │ÔÑÃ/70 ÌÅ Ëà                                                             

                                                                                                                                                                    

│Ïåðãîíàë [Ìåíîòðîïèí] {ôîëëèêóëîñòèìóëèðóþùèé     │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratoires Serono SA        │005781,       

│ãîðìîí 75 ÌÅ, ëþòåèíèçèðóþùèé ãîðìîí 75 ÌÅ;       │[G03GA02]                               │ïðèãîòîâëåíèÿ âíóòðèìûøå÷íîãî │(Øâåéöàðèÿ)                   │24.02.95      

│ôîëëèêóëîñòèìóëèðóþùèé ãîðìîí 150 ÌÅ,                                                     │ðàñòâîðà (àìïóëû) /â                                                      

│ëþòåèíèçèðóþùèé ãîðìîí 150 ÌÅ}                                                            │êîìïëåêòå ñ ðàñòâîðèòåëåì/ 75 │                                            

                                                                                          │ÌÅ ÔÑÃ/75 ÌÅ ËÃ, 150 ÌÅ                                                   

                                                                                          │ÔÑÃ/150 ÌÅ Ëà                                                            

                                                                                                                                                                    

│Ïåðãîíàë [Ìåíîòðîïèí] {ôîëëèêóëîñòèìóëèðóþùèé     │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratorious Serono SA       │005782,       

│ãîðìîí 75 ÌÅ, ëþòåèíèçèðóþùèé ãîðìîí 75 ÌÅ}       │[G03GA02]                               │ïðèãîòîâëåíèÿ âíóòðèìûøå÷íîãî │(Èñïàíèÿ)                     │24.02.95      

                                                                                          │ðàñòâîðà (àìïóëû) /â                                                      

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/ 75 │                                            

                                                                                          │ÌÅ ÔÑÃ/75 ÌÅ Ëà                                                          

                                                                                                                                                                    

│Ïåðãîíàë [Ìåíîòðîïèí] {ôîëëèêóëîñòèìóëèðóþùèé     │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Serono Pharma Spa (Èòàëèÿ)    │00181,        

│ãîðìîí 75 ÌÅ, ëþòåèíèçèðóþùèé ãîðìîí 75 ÌÅ;       │[G03GA02]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │18.04.95,     

│ôîëëèêóëîñòèìóëèðóþùèé ãîðìîí 150 ÌÅ,                                                     │ðàñòâîðà (àìïóëû) /â                                        │29.10.71,     

│ëþòåèíèçèðóþùèé ãîðìîí 150 ÌÅ}                                                            │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                  │30.11.83      

                                                                                          │75, 150 ÌÅ                                                                

                                                                                                                                                                     

│Ïåðãîòàéì [Êëîìèôåí]                              │ýñòðîãåí [G03GB02]                      │òàáëåòêè 50 ìã                │Ares-Serono Group (Øâåéöàðèÿ) │002096,       

                                                                                                                                                      │02.04.91      

                                                                                                                                                                     

│Ïåðäèïèí [Íèêàðäèïèí]                             │ÁÌÊÊ [C08CA04]                          │òàáëåòêè 20 ìã                │Yamanouchi Pharmaceutical Co  │002656,       

                                                                                                                        │Ltd (ßïîíèÿ)                  │26.10.92      

                                                                                                                                                                     

│Ïåðäîëàí [Ïàðàöåòàìîë]                            │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Janssen Pharmaceutica         │006164,       

                                                  │ñðåäñòâî [N02BE01]                                                    │(Áåëüãèÿ)                     │16.06.95      

                                                                                                                                                                     

│Ïåðåêèñü âîäîðîäà Æèôðåð                          │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AX01]      │ðàñòâîð äëÿ íàðóæíîãî         │Gifrer Barbezat (Ôðàíöèÿ)     │007477,       

                                                                                          │ïðèìåíåíèÿ (ôëàêîíû) 3% - 5,                                │29.04.96      

                                                                                          │125 ìë; ñïðåé 125 ìë                                                      

                                                                                                                                                                    

│Ïåðèíîðì [Ìåòîêëîïðàìèä]                          │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Ipca Laboratories Ltd (Èíäèÿ) │01815, 19.04.90│

                                                                                          │èíúåêöèé (àìïóëû) 2 ìë;                                                   

                                                                                          │æèäêîñòü (ôëàêîíû) 100 ìë                                                 

                                                                                                                                                                    

│Ïåðèòîë [Öèïðîãåïòàäèí]                           │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 4 ìã                 │Egis (Âåíãðèÿ)                │2390,         

                                                  │[R06AX02]                                                                                           │18.02.75,     

                                                                                                                                                      │24.06.92      

                                                                                                                                                                    

│Ïåðèòîë [Öèïðîãåïòàäèí]                           │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ñèðîï                         │Egis (ÂÍÐ)                    │2572,         

                                                  │[R06AX02]                                                                                           │01.08.78,     

                                                                                                                                                      │18.08.89      

                                                                                                                                                                    

│Ïåðëèíãàíèò [Íèòðîãëèöåðèí]                       │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ðàñòâîð äëÿ èíôóçèé (àìïóëû)  │Schwarz GmbH (ÔÐÃ)            │01762, 22.02.90│

                                                                                          │10 ìë                                                                     

                                                                                                                                                                    

│Ïåðñàíòèí [Äèïèðèäàìîë]                           │âàçîäèëàòèðóþùåå ñðåäñòâî [B01AC07]     │äðàæå 25 ìã, 75 ìã; ðàñòâîð   │Boehringer Ingelheim          │00167,        

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 10 ìã - │International GmbH (Ãåðìàíèÿ) │24.10.83,     

                                                                                          │2 ìë                                                        │30.01.95      

                                                                                                                                                                    

│Ïåðñèâàò [Áåòàìåòàçîí]                            │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │ìàçü 5 ìã/5 ã; êðåì 5 ìã/5 ã  │Lennon Ltd (ÞÀÐ)              │005454,       

                                                  │ïðèìåíåíèÿ [D07AC01]                                                                                │02.11.94      

                                                                                                                                                                    

│Ïåðòè [Ïåôëîêñàöèí]                               │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Dr.Reddy's Laboratories Ltd   │002688,       

                                                  │[J01MA03]                                                             │(Èíäèÿ)                       │13.11.92      

                                                                                                                                                                    

│Ïåðôëîêñ [Ïåôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Dolphin Laboratories Ltd      │007050,       

                                                  │[J01MA03]                                                             │(Èíäèÿ)                       │06.02.96      

                                                                                                                                                                    

│Ïåòåõà [Ïðîòèîíàìèä]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AD01] │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Fatol Arzneimittel GmbH       │006449,       

                                                                                          │250 ìã                        │(Ãåðìàíèÿ)                    │29.08.95      

                                                                                                                                                                    

│Ïåòèëèë [Äåçèïðàìèí]                              │àíòèäåïðåññàíò [N06AA01]                │äðàæå 25 ìã; ðàñòâîð äëÿ      │Arzneimittelwerk Dresden GmbH │002975,       

                                                                                          │èíúåêöèé (àìïóëû) 25 ìã - 2 ìë│(ÔÐÃ)                         │21.04.93      

                                                                                                                                                                    

│Ïåôëàöèí [Ïåôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã; ðàñòâîð äëÿ  │Eczacibasi (Òóðöèÿ)           │002239,       

                                                  │[J01MA03]                               │èíúåêöèé (àìïóëû) 400 ìã - 5                                │27.08.91      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ïåôëàöèí [Ïåôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Egis (Âåíãðèÿ)                │002520,       

                                                  │[J01MA03]                               │400 ìã; ðàñòâîð äëÿ èíúåêöèé                                │19.06.92      

                                                                                          │(àìïóëû) 400 ìã - 5 ìë                                                    

                                                                                                                                                                    

│Ïåôëàöèí [Ïåôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã; ðàñòâîð äëÿ  │Rhone-Poulenc Rorer (Ôðàíöèÿ) │007170,       

                                                  │[J01MA03]                               │èíúåêöèé (àìïóëû) 400 ìã - 5                                │27.03.96      

                                                                                          │ìë                                                                         

                                                                                                                                                                    

│Ïåôëîáèä [Ïåôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Cadila Laboratories Ltd       │005691,       

                                                  │[J01MA03]                                                             │(Èíäèÿ)                       │26.01.95       

                                                                                                                                                                    

│Ïåôëîêñàöèí [Ïåôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa, Grodziskie Zaklady     │005486,       

                                                  │[J01MA03]                               │400 ìã                        │Farmaceutyczne SA (Ïîëüøà)    │14.11.94      

                                                                                                                                                                    

│Ïè-êîêñ [Ïèðàçèíàìèä]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500, 700 ìã          │Dee-Pharma Ltd (Èíäèÿ)        │006527,       

                                                                                                                                                      │20.09.95      

                                                                                                                                                                    

│Ïèàññàí [Öåôàëåêñèí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250 ìã                │Chinoin (Âåíãðèÿ)             │2603,         

                                                                                                                                                      │06.11.90,     

                                                                                                                                                      │18.06.79      

                                                                                                                                                                    

│Ïèçèíà [Ïèðàçèíàìèä]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500 ìã               │Lupin Laboratories Ltd (Èíäèÿ)│002620,       

                                                                                                                                                      │10.09.92      

                                                                                                                                                                    

│Ïèëîêàðïèí [Ïèëîêàðïèí]                           │ì-õîëèíîìèìåòèê [S01EB01]               │êàïëè ãëàçíûå 1%, 2%          │Amoun Pharmaceutical          │003615,       

                                                                                                                        │Industries Co, Apic (Åãèïåò)  │24.12.93      

                                                                                                                                                                    

│Ïèëîêàðïèí [Ïèëîêàðïèí]                           │ì-õîëèíîìèìåòèê [S01EB01]               │êàïëè ãëàçíûå 1%, 2%          │Human (Âåíãðèÿ)               │003359,       

                                                                                                                                                      │22.09.93      

                                                                                                                                                                    

│Ïèëîêàðïèí [Ïèëîêàðïèí]                           │ì-õîëèíîìèìåòèê [S01EB01]               │êàïëè ãëàçíûå (ôëàêîíû) 0.5%, │Rugby (ÑØÀ)                   │005136,       

                                                                                          │1%, 2%, 4%, 6%                                              │15.07.94      

                                                                                                                                                                    

│Ïèëîöèä [Âèñìóòà òðèêàëèÿ äèöèòðàò]               │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðåïàðàò      │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Merck (india) Ltd (Èíäèÿ)     │005667,       

                                                  │âèñìóòà [A02BX05]                       │îáîëî÷êîé                                                   │23.01.95      

                                                                                                                                                                    

│Ïèìàäèí [Àìèíîïèðèäèí]                            │ðåàêòèâàòîð õîëèíýñòåðàçû [V03AB]       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pharmachim (Áîëãàðèÿ)         │2497,         

                                                                                          │2 ìë                                                        │15.07.76,     

                                                                                                                                                      │25.03.87      

                                                                                                                                                                    

│Ïèìàôóêîðò {ãèäðîêîðòèçîí 10 ìã, íàòàìèöèí 10 ìã, │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │êðåì; ìàçü; ëîñüîí            │Yamanouchi Europe B.V.        │006643,       

│íåîìèöèí 3.5 ìã}                                  │ñðåäñòâî [D07CA01]                                                    │(Íèäåðëàíäû)                  │13.02.96      

                                                                                                                                                                    

│Ïèìàôóöèí [Íàòàìèöèí]                             │ïðîòèâîãðèáêîâîå ñðåäñòâî               │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Yamanouchi Europe B.V.        │006642,       

                                                  │[A07AA03][D01AA02][G01AA02]             │100 ìã; ñâå÷è âàãèíàëüíûå 100 │(Íèäåðëàíäû)                  │13.02.96      

                                                                                          │ìã; ñóñïåíçèÿ äëÿ íàðóæíîãî                                               

                                                                                          │ïðèìåíåíèÿ 2.5%; êðåì 2%                                                  

                                                                                                                                                                    

│Ïèìèäåëü [Ïèïåìèäèíîâàÿ êèñëîòà]                  │ïðîòèâîìèêðîáíîå ñðåäñòâî, õèíîëîí      │êàïñóëû 200 ìã                │Krka (Ñëîâåíèÿ)               │006626,       

                                                  │[G04AB03]                                                                                           │18.01.96      

                                                                                                                                                                    

│Ïèïåðàöèëëèí [Ïèïåðàöèëëèí]                       │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ëèîôèëèç.ïîðîøîê äëÿ          │Pharmachim (Áîëãàðèÿ)         │003873,       

                                                  │[J01CA12]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │26.04.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1, 2, 3, 4 │                                            

                                                                                          │ã                                                                         

                                                                                                                                                                    

│Ïèïîëüôåí [Ïðîìåòàçèí]                            │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │äðàæå 25 ìã; ðàñòâîð äëÿ      │Egis (Âåíãðèÿ)                │006285,       

                                                  │[R06AD02]                               │èíúåêöèé (àìïóëû) 50 ìã/2 ìë                                │14.07.95      

                                                                                                                                                                    

│Ïèïîðòèë [Ïèïîòèàçèí]                             │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC04]     │òàáëåòêè 10 ìã; êàïëè 4%      │Rhone-Poulenc Rorer (Ôðàíöèÿ) │00786,        

                                                                                                                                                      │02.09.80,     

                                                                                                                                                      │25.05.94      

                                                                                                                                                                    

│Ïèïîðòèë [Ïèïîòèàçèí]                             │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC04]     │òàáëåòêè 10 ìã                │Rhone-Poulenc (india) Ltd     │002150,       

                                                                                                                        │(Èíäèÿ)                       │29.05.91       

                                                                                                                                                                    

│Ïèïîðòèë [Ïèïîòèàçèí]                             │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC04]     │êàïëè 4%                      │Rhone-Poulenc Pharma SA       │002384,       

                                                                                                                        │(Èñïàíèÿ)                     │28.01.92       

                                                                                                                                                                    

│Ïèïîðòèë [Ïèïîòèàçèí]                             │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC04]     │òàáëåòêè 10 ìã                │Torrent Exports Ltd (Èíäèÿ)   │002083,       

                                                                                                                                                      │15.03.91      

                                                                                                                                                                    

│Ïèïîðòèë Ë4 [Ïèïîòèàçèí]                          │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC04]     │ðàñòâîð äëÿ âíóòðèìûøå÷íûõ    │Rhone-Poulenc Rorer (Ôðàíöèÿ) │00806,        

                                                                                          │èíúåêöèé (àìïóëû) 2.5% - 1                                  │12.07.94,     

                                                                                          │ìë, 4 ìë                                                    │17.10.80      

                                                                                                                                                                    

│Ïèïîðòèë Ë4 [Ïèïîòèàçèí]                          │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC04]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rhone-Poulenc Pharma SA       │002385,       

                                                                                          │2.5% - 1 ìë, 4 ìë             │(Èñïàíèÿ)                     │28.01.92      

                                                                                                                                                                    

│Ïèïðàêñ [Ïèïåðàöèëëèí]                            │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eczacibasi (Òóðöèÿ)           │005085,       

                                                  │[J01CA12]                               │èíúåêöèîííîãî ðàñòâîðà                                      │05.07.94      

                                                                                          │(ôëàêîíû) 2 ã /â êîìïëåêòå ñ                                              

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Ïèïðàöèë [Ïèïåðàöèëëèí]                           │ïåíèöèëëèí øèðîêîãî ñïåêòðà [J01CA12]   │ëèîôèëèç.ïîðîøîê äëÿ          │Lederle (ÑØÀ)                 │006629,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │29.01.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) 2 ã, 4 ã                                               

                                                                                                                                                                    

│Ïèðàáåíå [Ïèðàöåòàì]                              │íîîòðîïíîå ñðåäñòâî [N06BX03]           │êàïñóëû 400 ìã; ðàñòâîð äëÿ   │Ludwig Merckle GmbH (Àâñòðèÿ) │002982,       

                                                                                          │èíúåêöèé (àìïóëû) 20% - 5 ìë; │                              │27.04.93      

                                                                                          │ñèðîï 33.3 ã - 100 ìë                                                     

                                                                                                                                                                    

│Ïèðàáåíå [Ïèðàöåòàì]                              │íîîòðîïíîå ñðåäñòâî [N06BX03]           │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ludwig Merckle GmbH (Àâñòðèÿ) │006860,       

                                                                                          │800, 1200 ìã                                                │28.11.95      

                                                                                                                                                                    

│Ïèðàáóòîë {ôåíèëáóòàçîí 0.75 ã, àìèíîôåíàçîí 0.75 │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │äðàæå; ðàñòâîð äëÿ èíúåêöèé   │Spofa (×åõîñëîâàêèÿ)          │2260,         

│ã, òðèìåêàèí 50 ìã - àìïóëû; ôåíèëáóòàçîí 0.125   │ñðåäñòâî [N02BB53]                      │(àìïóëû) 5 ìë                                               │05.12.84,     

│ã, àìèíîôåíàçîí 0.125 ã - äðàæå}                                                                                                                      │29.07.71      

                                                                                                                                                                    

│Ïèðàçèíàìèä [Ïèðàçèíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè                      │Armour (Èíäèÿ)                │02040, 31.01.91│

                                                                                                                                                                    

│Ïèðàçèíàìèä [Ïèðàçèíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500 ìã               │Sanavita Gesundcheitsmittel & │006754,       

                                                                                                                        │Co Kg (Ãåðìàíèÿ)              │27.10.95      

                                                                                                                                                                    

│Ïèðàçèíàìèä [Ïèðàçèíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 250, 500 ìã          │Cheil Foods & Chemicals Inc   │002842,       

                                                                                                                        │(Êîðåÿ Þæíàÿ)                 │15.02.93      

                                                                                                                                                                    

│Ïèðàçèíàìèä [Ïèðàçèíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500 ìã               │Ipca Laboratories Ltd (Èíäèÿ) │005532,       

                                                                                                                                                      │30.11.94      

                                                                                                                                                                    

│Ïèðàçèíàìèä [Ïèðàçèíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500 ìã               │Krka (Ñëîâåíèÿ)               │006637,       

                                                                                                                                                      │06.02.96      

                                                                                                                                                                    

│Ïèðàçèíàìèä [Ïèðàçèíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500 ìã               │Rusan Pharma (Èíäèÿ)          │007608,       

                                                                                                                                                      │25.06.96      

                                                                                                                                                                    

│Ïèðàçèíàìèä [Ïèðàçèíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500, 750, 1000 ìã    │Wave International (Èíäèÿ)    │007544,       

                                                                                                                                                      │27.05.96      

                                                                                                                                                                    

│Ïèðàçèíàìèä [Ïèðàçèíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 250, 500 ìã          │Yuhan Corporation (Êîðåÿ      │003219,       

                                                                                                                        │Þæíàÿ)                        │10.08.93      

                                                                                                                                                                    

│Ïèðàìåì [Ïèðàöåòàì]                               │íîîòðîïíîå ñðåäñòâî [N06BX03]           │òàáëåòêè; àìïóëû              │Pharmachim (ÍÐÁ)              │2660, 02.07.81 │

                                                                                                                                                                    

│Ïèðàìåì [Ïèðàöåòàì]                               │íîîòðîïíîå ñðåäñòâî [N06BX03]           │êàïñóëû 400 ìã; ñèðîï         │Pharmachim (ÍÐÁ)              │2993, 30.10.90 │

                                                                                          │(ôëàêîíû) 20% - 125 ìë                                                     

                                                                                                                                                                    

│Ïèðàíàë {àìèíîôåíàçîí 0.25 ã, ìåòàìèçîë 0.25 ã}   │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Pharmachim (Áîëãàðèÿ)         │2141,         

                                                  │ñðåäñòâî [N02BB52]                                                                                  │10.11.85,     

                                                                                                                                                      │22.10.70      

                                                                                                                                                                    

│Ïèðàíàë {àìèíîôåíàçîí 0.25 ã, ìåòàìèçîë 0.25 ã}   │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Pharmachim (ÍÐÁ)              │2565, 05.07.78 │

                                                  │ñðåäñòâî [N02BB52]                                                                                                

                                                                                                                                                                    

│Ïèðàíòåë [Ïèðàíòåë]                               │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CC01]   │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Terpol (Ïîëüøà)               │007264,       

                                                                                          │50 ìã/ìë - 15 ìë                                            │25.07.96      

                                                                                                                                                                    

│Ïèðàíòåë [Ïèðàíòåë]                               │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CC01]   │òàáëåòêè 250 ìã               │Polfa (Ïîëüøà)                │2686,         

                                                                                                                                                      │20.01.82,     

                                                                                                                                                      │16.06.93      

                                                                                                                                                                    

│Ïèðàôàò [Ïèðàçèíàìèä]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500 ìã               │Fatol Arzneimittel GmbH       │006447,       

                                                                                                                        │(Ãåðìàíèÿ)                    │29.08.95      

                                                                                                                                                                    

│Ïèðàöåòàì [Ïèðàöåòàì]                             │íîîòðîïíîå ñðåäñòâî [N06BX03]           │êàïñóëû 400 ìã                │Polfa Starogardzkie Zaklady   │006709,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │11.10.95      

                                                                                                                                                                    

│Ïèðàöåòàì-Ðàòèîôàðì [Ïèðàöåòàì]                   │íîîòðîïíîå ñðåäñòâî [N06BX03]           │ôèëìòàáëåòêè 800, 1200 ìã     │Ratiopharm GmbH & Co          │005128,       

                                                                                                                        │(Ãåðìàíèÿ)                    │14.07.94      

                                                                                                                                                                    

│Ïèðàöåòàì-Ðàòèîôàðì [Ïèðàöåòàì]                   │íîîòðîïíîå ñðåäñòâî [N06BX03]           │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ratiopharm GmbH & Co          │005410,       

                                                                                          │1 ã - 5 ìë                    │(Ãåðìàíèÿ)                    │19.10.94      

                                                                                                                                                                    

│Ïèðàöåòàì-Ðàòèîôàðì [Ïèðàöåòàì]                   │íîîòðîïíîå ñðåäñòâî [N06BX03]           │êàïñóëû 400 ìã                │Ratiopharm GmbH & Co          │005462,       

                                                                                                                        │(Ãåðìàíèÿ)                    │08.11.94      

                                                                                                                                                                    

│Ïèðâèíèóì [Ïèðâèíèÿ õëîðèä]                       │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CX01]   │ñóñïåíçèÿ 1.5 ã - 100 ìë      │Galena Opava (×åõèÿ)          │006492,       

                                                                                                                                                      │12.09.95      

                                                                                                                                                                    

│Ïèðåãåêñàë [Ïèðåíçåïèí]                           │ì-õîëèíîáëîêàòîð [A02BX03]              │òàáëåòêè 25, 50 ìã;           │Hexal Pharma GmbH (Ãåðìàíèÿ)  │006824,       

                                                                                          │ëèîôèëèç.ïîðîøîê äëÿ                                        │13.11.95      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 10 ìã /â                                               

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ïèðåí [Ïèðåíçåïèí]                                │ì-õîëèíîáëîêàòîð [A02BX03]              │òàáëåòêè 25, 50 ìã; ðàñòâîð   │Ludwig Merckle GmbH (Àâñòðèÿ) │002984,       

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 10 ìã - │                              │27.04.93      

                                                                                          │2 ìë                                                                      

                                                                                                                                                                    

│Ïèðåíçåïèí-Ðàòèîôàðì [Ïèðåíçåïèí]                 │ì-õîëèíîáëîêàòîð [A02BX03]              │òàáëåòêè 25 ìã                │Ratiopharm GmbH & Co          │006077,       

                                                                                                                        │(Ãåðìàíèÿ)                    │22.05.95      

                                                                                                                                                                    

│Ïèðåíöåïèí [Ïèðåíçåïèí]                           │ì-õîëèíîáëîêàòîð [A02BX03]              │òàáëåòêè 50 ìã                │CT-Arzneimittel Chemishe      │003212,       

                                                                                                                        │Tempelchof GmbH (ÔÐÃ)         │09.08.93      

                                                                                                                                                                    

│Ïèðèäîáåíå [Ïèðèäîêñèí]                           │âèòàìèí [A11HA02]                       │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ludwig Merckle GmbH (Àâñòðèÿ) │005682,       

                                                                                          │40 ìã; ðàñòâîð äëÿ èíúåêöèé                                 │24.01.95      

                                                                                          │(àìïóëû) 100 ìã - 2 ìë                                                    

                                                                                                                                                                    

│Ïèðèêàì [Ïèðîêñèêàì]                              │ÍÏÂÑ [M02AA07]                          │êàïñóëû 10, 20 ìã             │Cadila Laboratories Ltd       │002998,       

                                                                                                                        │(Èíäèÿ)                       │26.05.93       

                                                                                                                                                                    

│Ïèðèëàêñ [Áèñàêîäèë]                              │ñëàáèòåëüíîå ñðåäñòâî [A06AB02]         │ñâå÷è 10 ìã; òàáëåòêè         │Berlin-Chemie AG (Ãåðìàíèÿ)   │006409,       

                                                                                          │ïîêðûòûå îáîëî÷êîé 5 ìã                                     │15.08.95       

                                                                                                                                                                    

│Ïèðèìîë [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Amoun Pharmaceutical          │005297,       

                                                  ñðåäñòâî [N02BE01]                                                    │Industries Co, Apic (Åãèïåò)  │06.09.94      

                                                                                                                                                                    

Ïèðèìîë [Ïàðàöåòàìîë]                             àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         ñèðîï (ôëàêîíû) 150 ìã|5 ìë;  │Amoun Pharmaceutical          │006923,       

                                                  ñðåäñòâî [N02BE01]                      ñâå÷è 300 ìã                  │Industries Co, Apic (Åãèïåò)  │20.12.95      

                                                                                                                                                                    

Ïèðêîí [Ïèðâèíèÿ õëîðèä] {ïèðâèíèóì ýìáîíàò}      ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CX01]   ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Krewel Meuselbach GmbH        │007231,       

                                                                                          │25 ìë                         │(Ãåðìàíèÿ)                    │26.06.96      

                                                                                                                                                                    

Ïèðîêàì [Ïèðîêñèêàì]                              ÍÏÂÑ [M02AA07]                          òàáëåòêè 10, 20 ìã; ñâå÷è 20  │Ludwig Merckle GmbH (Àâñòðèÿ) │002983,       

                                                                                          ìã; ðàñòâîð äëÿ èíúåêöèé                                    │27.04.93      

                                                                                          │(àìïóëû) 1 ìë, 2 ìë                                                       

                                                                                                                                                                    

Ïèðîêñ [Ïèðîêñèêàì]                               ÍÏÂÑ [M02AA07]                          êàïñóëû 10, 20 ìã             │Cipla Ltd (Èíäèÿ)             │002068,       

                                                                                                                                                      │14.03.91      

                                                                                                                                                                    

Ïèðîêñ [Ïèðîêñèêàì]                               ÍÏÂÑ [M02AA07]                          ãåëü 0.5%                     │Cipla Ltd (Èíäèÿ)             │002989,       

                                                                                                                                                      │28.04.93      

                                                                                                                                                                    

Ïèðîêñ [Ïèðîêñèêàì]                               ÍÏÂÑ [M02AA07]                          òàáëåòêè ðàñòâîðèìûå 20 ìã;   │Cipla Ltd (Èíäèÿ)             │005825,       

                                                                                          ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                              │15.03.95      

                                                                                          │20 ìã/1 ìë, 40 ìã/2 ìë                                                    

                                                                                                                                                                    

Ïèðîêñèêàì [Ïèðîêñèêàì]                           ÍÏÂÑ [M02AA07]                          ñâå÷è 20 ìã                   │Jenapharm GmbH (Ãåðìàíèÿ)     │005057,       

                                                                                                                                                      │30.06.94      

                                                                                                                                                                    

Ïèðîêñèêàì [Ïèðîêñèêàì]                           ÍÏÂÑ [M02AA07]                          êàïñóëû 10, 20 ìã             │Norton Healthcare Ltd         │003243,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │18.08.93      

                                                                                                                                                                    

Ïèðîêñèêàì [Ïèðîêñèêàì]                           ÍÏÂÑ [M02AA07]                          êàïñóëû 10, 20 ìã             │Pharmachim (Áîëãàðèÿ)         │003872,       

                                                                                                                                                      │26.04.94      

                                                                                                                                                                    

Ïèðîêñèêàì [Ïèðîêñèêàì]                           ÍÏÂÑ [M02AA07]                          êàïñóëû 10 ìã                 │Pharmaline Ltd (Ëèâàí)        │007120,       

                                                                                                                                                      │01.03.96      

                                                                                                                                                                    

Ïèðîêñèêàì [Ïèðîêñèêàì]                           ÍÏÂÑ [M02AA07]                          òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa (Ïîëüøà)                │2874, 16.10.87 │

                                                                                          │10 ìã                                                                     

                                                                                                                                                                    

Ïèðîêñèêàì [Ïèðîêñèêàì]                           ÍÏÂÑ [M02AA07]                          ñâå÷è 10, 20 ìã               │Polfa (Ïîëüøà)                │002623,       

                                                                                                                                                      │10.09.92      

                                                                                                                                                                    

Ïèðîêñèêàì [Ïèðîêñèêàì]                           ÍÏÂÑ [M02AA07]                          òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa (Ïîëüøà)                │003568,       

                                                                                          │20 ìã                                                       │08.12.93      

                                                                                                                                                                    

Ïèðîêñèêàì [Ïèðîêñèêàì]                           ÍÏÂÑ [M02AA07]                          êàïñóëû 10, 20 ìã             │Schiapparelli Searle (ÑØÀ)    │002627,       

                                                                                                                                                      │11.09.92      

                                                                                                                                                                    

Ïèðîêñèêàì-Éåíàôàðì [Ïèðîêñèêàì]                  ÍÏÂÑ [M02AA07]                          êàïñóëû 10, 20 ìã             │Jenapharm GmbH (Ãåðìàíèÿ)     │003606,       

                                                                                                                                                      │20.12.93      

                                                                                                                                                                    

Ïèðîêñèêàì-Ðàòèîôàðì [Ïèðîêñèêàì]                 ÍÏÂÑ [M02AA07]                          òàáëåòêè 10, 20 ìã            │Ratiopharm GmbH & Co          │005125,       

                                                                                                                        │(Ãåðìàíèÿ)                    │14.07.94      

                                                                                                                                                                    

Ïèðîêñèêàì-Òåâà [Ïèðîêñèêàì]                      ÍÏÂÑ [M02AA07]                          êàïñóëû 10, 20 ìã             │Teva Pharmaceutical           │005569,        

                                                                                                                        │Industries Ltd (Èçðàèëü)      │15.12.94      

                                                                                                                                                                    

Ïèðîðåóì [Ïèðîêñèêàì]                             ÍÏÂÑ [M02AA07]                          òàáëåòêè 10, 20 ìã; ñâå÷è 20  │Hexal Pharma GmbH (Ãåðìàíèÿ)  │003824,        

                                                                                          ìã; ðàñòâîð äëÿ èíúåêöèé                                    │05.04.94      

                                                                                          │(àìïóëû) 20 ìã/ìë                                                         

                                                                                                                                                                     

Ïèðîôëàì [Ïèðîêñèêàì]                             ÍÏÂÑ [M02AA07]                          êàïñóëû æåëàòèíîâûå 20 ìã     │Intas                         │005766,       

                                                                                                                        │International-Pharmaceuticals │20.02.95      

                                                                                                                        │(Èíäèÿ)                                      

                                                                                                                                                                    

Ïèöèëëèí [Ïèïåðàöèëëèí]                           àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Laboratorio Pharmacheutica    │006986,       

                                                  │[J01CA12]                               │èíúåêöèîííîãî ðàñòâîðà        │S.T. (Èòàëèÿ)                 │16.01.96      

                                                                                          │(ôëàêîíû) 1 ã, 2 ã /â                                                     

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│ÏÊ-Ìåðö [Àìàíòàäèí]                               │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 100 ìã; ðàñòâîð äëÿ  │Merz Co GmbH (ÔÐÃ)            │002944,       

                                                  │[N04BB01]                               │èíôóçèé (ôëàêîíû) 200 ìã -                                  │31.03.93      

                                                                                          │500 ìë                                                                    

                                                                                                                                                                    

│Ïëàêâåíèë [Ãèäðîêñèõëîðîõèí]                      │èììóíîäåïðåññàíò [P01BA02]              │òàáëåòêè 200 ìã               │Sterling-Winthrop             │01268, 01.04.86│

                                                                                                                        │(Âåëèêîáðèòàíèÿ)                            

                                                                                                                                                                    

│Ïëàòàìèí [Öèñïëàòèí]                              │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Farmitalia Carlo Erba (Èòàëèÿ)│003610,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │20.12.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 10, 25, 50 │                                            

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Ïëàòèäèàì [Öèñïëàòèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Lachema (×ÑÔÐ)                │002186,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │08.07.91      

                                                                                          │ðàñòâîðà (ôëàêîíû) 50 ìã                                                  

                                                                                                                                                                    

│Ïëàòèäèàì [Öèñïëàòèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Lachema (×åõèÿ)               │006647,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │19.02.96      

                                                                                          │(ôëàêîíû) 10, 25 ìã                                                       

                                                                                                                                                                    

│Ïëàòèäèàì [Öèñïëàòèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ðàñòâîð äëÿ èíúåêöèé          │Lachema (×åõèÿ)               │007513,       

                                                                                          │(ôëàêîíû) 10 ìã/20 ìë, 25                                   │15.05.96      

                                                                                          │ìã/50 ìë, 50 ìã/100 ìë                                                    

                                                                                                                                                                    

│Ïëàòèìèò [Öèñïëàòèí]                              │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Pliva (Õîðâàòèÿ)              │003675,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │08.02.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 10 ìã                                                  

                                                                                                                                                                    

│Ïëàòèíîë [Öèñïëàòèí]                              │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ðàñòâîð äëÿ èíúåêöèé          │Bristol-Myers Squibb (ÑØÀ)    │002364,       

                                                                                          │(ôëàêîíû) 10, 25, 50 ìã                                     │27.01.92      

                                                                                                                                                                    

│Ïëåíäèë [Ôåëîäèïèí]                               │ÁÌÊÊ [C08CA02]                          │òàáëåòêè äëèòåëüíîãî          │Astra (Øâåöèÿ)                │002752,       

                                                                                          │âûñâîáîæäåíèÿ 5, 10 ìã                                      │15.12.92      

                                                                                                                                                                    

│Ïëèâàëãèí {ïàðàöåòàìîë 0.21 ã, ïðîïèôåíàçîí 0.21  │àíàëüãåòè÷åñêîå è ñïàçìîëèòè÷åñêîå      │òàáëåòêè                      │Pliva (Õîðâàòèÿ)              │002456,       

│ã, êîôåèí 50 ìã, ôåíîáàðáèòàë 25 ìã, êîäåèí 10 ìã}│ñðåäñòâî [N02BE51]                                                                                  │24.04.92      

                                                                                                                                                                    

│Ïëèâàñåïò [Õëîðãåêñèäèí]                          │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC02]      │êîíöåíòðàò îêðàøåííûé 5%;     │Pliva (Õîðâàòèÿ)              │002840,       

                                                                                          │êîíöåíòðàò íåîêðàøåííûé 5%;                                 │11.02.93      

                                                                                          │êðåì 1%                                                                   

                                                                                                                                                                    

│Ïëèâàñåïò [Õëîðãåêñèäèí]                          │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC02]      │ýìóëüñèÿ (ôëàêîíû) 10 ìã/ã    │Pliva (Õîðâàòèÿ)              │003838,       

                                                                                                                                                      │07.04.94       

                                                                                                                                                                    

│Ïëèâàñåïò [Õëîðãåêñèäèí]                          │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC02]      │ðàñòâîð ïåíîîáðàçóþùèé 4.5    │Pliva (Õîðâàòèÿ)              │003839,       

                                                                                          │ã|100 ìë                                                    │07.04.94       

                                                                                                                                                                    

│Ïëèâàñåïò [Õëîðãåêñèäèí] {õëîðãåêñèäèí 0.5 ã,     │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC02]      │íàñòîéêà 500 ìã / ýòàíîë 80   │Pliva (Õîðâàòèÿ)              │003840,       

│ýòàíîë 80}                                                                                                                                            │07.04.94      

                                                                                                                                                                    

│Ïëèâàñåïò ãëþêîíàò 5% áåç ÏÀ [Õëîðãåêñèäèí]      │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC02]      │ðàñòâîð (ôëàêîíû)             │Pliva (Õîðâàòèÿ)              │005365,       

                                                                                                                                                      │27.09.94      

                                                                                                                                                                    

│Ïëèâàñåïò Í [Õëîðãåêñèäèí]                        │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC02]      │ðàñòâîð (êàíèñòðû             │Pliva (Õîðâàòèÿ)              │003837,       

                                                                                          │ïëàñòèêîâûå) 4 ã|100 ìë - 0.5 │                              │07.04.94      

                                                                                          │ë, 1 ë, 5 ë                                                               

                                                                                                                                                                    

│Ïëèäîë [Àöåòèëñàëèöèëîâàÿ êèñëîòà]                │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 100, 300 ìã          │Pliva SA (Õîðâàòèÿ)           │006075,       

                                                                                                                                                      │22.05.95      

                                                                                                                                                                    

│Ïëèäîë 300 [Àöåòèëñàëèöèëîâàÿ êèñëîòà]            │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 300 ìã               │Pliva SA (Õîðâàòèÿ)           │006495,       

                                                                                                                                                      │12.09.95      

                                                                                                                                                                    

│Ïëþñ æåëåçî + Ñ {æåëåçà ãëþêîíàò 35 ìã,           │ãåìîïîýçà ñòèìóëÿòîð, ïðåïàðàò æåëåçà   │òàáëåòêè øèïó÷èå              │Pharmavit (Âåíãðèÿ)           │006900,       

│àñêîðáèíîâàÿ êèñëîòà 75 ìã, ëèìîííàÿ êèñëîòà 1800 │[B03AE10]                                                                                           │18.12.95      

│ìã, íàòðèÿ ãèäðîêàðáîíàò 700 ìã}                                                                                                                                    

                                                                                                                                                                    

│ïìñ-Àëþìèíèÿ, ìàãíèÿ è ñèìåòèêîíà {àëãåëäðàò 40   │àíòàöèäíîå ñðåäñòâî [A02AF]             │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Pharmascience Inc (Êàíàäà)    │005943,       

│ìã, ìàãíèÿ ãèäðîêñèä 40 ìã, ñèìåòèêîí 5 ìã}                                                                                                           │11.04.95      

                                                                                                                                                                    

│ïìñ-Æåëåçà ñóëüôàò [Æåëåçà ñóëüôàò]               │ãåìîïîýçà ñòèìóëÿòîð, ïðåïàðàò æåëåçà   │òàáëåòêè 300 ìã               │Pharmascience Inc (Êàíàäà)    │005811,       

                                                  │[B03AA07]                                                                                           │09.03.95      

                                                                                                                                                                    

│ïìñ-ïðîïðàíîëîë [Ïðîïðàíîëîë]                     │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 10, 40 ìã            │Pharmascience Inc (Êàíàäà)    │005171,       

                                                                                                                                                      │21.07.94      

                                                                                                                                                                    

│Ïîçèòàí [Êåòîòèôåí]                               │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã                 │Polfa, Poznanskie Zaklady     │003565,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │08.12.93      

                                                                                                                                                                    

│Ïîëèæèíàêñ {íåîìèöèí 35000 ÅÄ, ïîëèìèêñèí  35000 │àíòèñåïòè÷åñêîå ñðåäñòâî [G01AX]        │êàïñóëû âàãèíàëüíûå 35000     │Innothera/innotech            │002807,       

│ÅÄ, íèñòàòèí 100000 ÅÄ}                                                                   │ÌÅ/35000 ÌÅ/100000 ÌÅ         │International (Ôðàíöèÿ)       │13.01.93      

                                                                                                                                                                    

│Ïîëèéîäèí [Ïîâèäîí-Éîäèí]                         │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AG02]      │ðàñòâîð äëÿ íàðóæíîãî         │Gifrer Barbezat (Ôðàíöèÿ)     │007562,       

                                                                                          │ïðèìåíåíèÿ (ôëàêîíû                                         │03.06.96      

                                                                                          │ïëàñòèêîâûå) 10% - 45 ìë                                                  

                                                                                                                                                                    

│Ïîëèìèíåðîë                                       │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî äëÿ      │æèäêîñòü (ôëàêîíû) 100 ìë     │Pharmachim (Áîëãàðèÿ)         │2131,         

                                                  │ìåñòíîãî ïðèìåíåíèÿ [D11AX]                                                                         │10.11.85,     

                                                                                                                                                      │16.03.70      

                                                                                                                                                                    

│Ïîëèñîðá                                          │àáñîðáèðóþùåå ñðåäñòâî [D11AX]          │ïîðîøîê (áóòûëêè äëÿ êðîâè) 3 │(Óêðàèíà)                     │93/84/5       

                                                                                          │ã/125 ìë, 6 ã/250 ìë, 12                                                  

                                                                                          │ã/500 ìë                                                                  

                                                                                                                                                                    

│Ïîëèñîðá ÌÏ                                       │àáñîðáèðóþùåå ñðåäñòâî [D11AX]          │ïîðîøîê (áóòûëêè) 12 ã;       │(Óêðàèíà)                     │96/50/11      

                                                                                          │ïîðîøîê (ïàêåòû îäíîðàçîâûå)                                              

                                                                                          │1, 2 ã; ïîðîøîê (ïàêåòû                                                   

                                                                                          │ïîëèýòèëåíîâûå) 50 ã                                                      

                                                                                                                                                                    

│Ïîëüêîðòîëîí [Òðèàìöèíîëîí]                       │ãëþêîêîðòèêîñòåðîèä [D07AB09]           │ìàçü 0.1%; êðåì 0.1%          │Polfa (Ïîëüøà)                │2887, 15.02.88 │

                                                                                                                                                                     

│Ïîëüêîðòîëîí [Òðèàìöèíîëîí]                       │ãëþêîêîðòèêîñòåðîèä [H02AB08]           │òàáëåòêè 4 ìã                 │Polfa, Pabianickie Zaklady    │006592,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │02.11.95      

                                                                                                                                                                     

│Ïîëüêîðòîëîí ÒÑ {òðèàìöèíîëîí 0.25 ìã,            │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │àýðîçîëü                      │Polfa (Ïîëüøà)                │2362,         

│òåòðàöèêëèí 10 ìã - 1 ìë}                         │ñðåäñòâî [D07CB01]                                                                                  │20.02.85,     

                                                                                                                                                      │25.03.74      

                                                                                                                                                                    

│Ïîëüïðåññèí [Ïðàçîçèí]                            │àëüôà-àäðåíîáëîêàòîð [C02CA01]          │òàáëåòêè 1, 2, 5 ìã           │Polfa, Starogardzkie Zaklady  │006202,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │21.06.95      

                                                                                                                                                                    

│Ïîðòàë [Ôëóîêñåòèí]                               │àíòèäåïðåññàíò [N06AB03]                │êàïñóëû 20 ìã                 │Lek D.D. (Ñëîâåíèÿ)           │006899,       

                                                                                                                                                      │18.12.95      

                                                                                                                                                                    

│Ïîðòàëàê {ëàêòóëîçà 67 ã, ãàëàêòîçà 11 ã, ëàêòîçà │ãèïîàçîòåìè÷åñêîå ñðåäñòâî [A06AD11]    │ñèðîï                         │Podravka-Belupo (Þãîñëàâèÿ)   │01236, 27.12.85│

│6 ã - 100 ìë}                                                                                                                                                       

                                                                                                                                                                    

│Ïîñòèíîð [Ëåâîíîðãåñòðåë]                         │ïðîãåñòàãåí [G03AC03]                   │òàáëåòêè 0.75 ìã              │Gedeon Richter (Âåíãðèÿ)      │2680,         

                                                                                                                                                      │01.12.94,     

                                                                                                                                                      │19.01.82      

                                                                                                                                                                    

│Ïðàçîçèí [Ïðàçîçèí]                               │àëüôà-àäðåíîáëîêàòîð [C02CA01]          │òàáëåòêè 0.5, 1, 2, 5 ìã      │Norton Healthcare Ltd         │003593,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │16.12.93      

                                                                                                                                                                    

│Ïðàçîçèí-Ôàðìàõèì [Ïðàçîçèí]                      │àëüôà-àäðåíîáëîêàòîð [C02CA01]          │òàáëåòêè 1 ìã, 5 ìã           │Pharmachim (Áîëãàðèÿ)         │003961,       

                                                                                                                                                      │31.05.94      

                                                                                                                                                                    

│Ïðàçîçèíáåíå [Ïðàçîçèí]                           │àëüôà-àäðåíîáëîêàòîð [C02CA01]          │òàáëåòêè 1, 2, 5 ìã           │Ludwig Merckle GmbH (Àâñòðèÿ) │003686,       

                                                                                                                                                      │10.02.94      

                                                                                                                                                                    

│Ïðàêòîí [Ñïèðîíîëàêòîí]                           │äèóðåòè÷åñêîå êàëèéñáåðåãàþùåå ñðåäñòâî │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Biogalenique     │002406,       

                                                  │[C03DA01]                               │äåëèìûå 50 ìã                 │(Ôðàíöèÿ)                     │30.01.92      

                                                                                                                                                                    

│Ïðàìîêñèí [Ïðàìîêàèí]                             │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C05AD07] │êðåì (òóáû) 1%                │American Drug Company (ÑØÀ)   │006187,       

                                                                                                                                                      │14.06.95      

                                                                                                                                                                    

│Ïðå-ïàð [Ðèòîäðèí]                                │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Duphar Bv (Íèäåðëàíäû)        │00677,        

                                                  │[G02CA01]                               │èíúåêöèé (àìïóëû) 10 ìã/ìë                                  │21.05.79,     

                                                                                                                                                      │26.01.93      

                                                                                                                                                                    

│Ïðåãíèë [Ãîíàäîòðîïèí õîðèîíè÷åñêèé]              │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Organon (Íèäåðëàíäû)          │007267,       

                                                  │[G03GA01]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │30.07.96      

                                                                                          │ðàñòâîðà (àìïóëû) 500, 1500,                                              

                                                                                          │5000 ÌÅ /â êîìïëåêòå ñ                                                    

                                                                                          │ðàñòâîðèòåëåì (àìïóëû) 1 ìë/                                              

                                                                                                                                                                    

│Ïðåãíèë [Ãîíàäîòðîïèí õîðèîíè÷åñêèé]              │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Organon Ilaclary (Òóðöèÿ)     │003044,       

                                                  │[G03GA01]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │08.06.93      

                                                                                          │ðàñòâîðà (àìïóëû) 500, 1500,                                              

                                                                                          │5000 ÌÅ /â êîìïëåêòå ñ                                                    

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Ïðåäèàí [Ãëèêëàçèä]                               │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 80 ìã                │Zorka Pharma (Þãîñëàâèÿ)      │007208,       

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB09]                                                                       │04.06.96      

                                                                                                                                                                    

│Ïðåäíèãåêñàë [Ïðåäíèçîëîí]                        │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hexal Pharma GmbH (ÔÐÃ)       │003185,       

                                                                                          │(àìïóëû) 1 ìë - 25, 50 ìã                                   │03.08.93      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ìàçèïðåäîí]                          │ãëþêîêîðòèêîñòåðîèä [H02AB]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │2091,          

                                                                                          │30 ìã/1 ìë                                                  │01.07.70,     

                                                                                                                                                      │02.11.84,     

                                                                                                                                                      │21.03.95       

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Arab Pharmaceutical           │003756,       

                                                                                                                        │Manufacturing Co Ltd          │15.03.94      

                                                                                                                        │(Èîðäàíèÿ)                                  

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã; ñóñïåíçèÿ äëÿ  │Sanavita Gesundcheitsmittel & │006846,       

                                                                                          │èíúåêöèé (ôëàêîíû) 25 ìã - 1  │Co Kg (Ãåðìàíèÿ)              │22.11.95      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Fabrica Socho (Èíäîíåçèÿ)     │005065,       

                                                                                                                                                      │30.06.94      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Gedeon Richter (Âåíãðèÿ)      │2651,         

                                                                                                                                                      │09.12.80,     

                                                                                                                                                      │25.01.93      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [D07AA03]           │ìàçü 0.5%                     │Gedeon Richter (Âåíãðèÿ)      │2668,         

                                                                                                                                                      │10.11.81,     

                                                                                                                                                      │25.01.93      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [S01BA04]           │êàïëè ãëàçíûå (ôëàêîíû) 0.3%  │Gedeon Richter (Âåíãðèÿ)      │006576,       

                                                                                                                                                      │28.09.95      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Ipca Laboratories Ltd (Èíäèÿ) │003148,       

                                                                                                                                                      │07.07.93      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Jenapharm GmbH (Ãåðìàíèÿ)     │005059,       

                                                                                                                                                      │30.06.94      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã; ðàñòâîð äëÿ    │M.J.Pharmaceuticals Ltd       │006207,       

                                                                                          │èíúåêöèé (àìïóëû) 30 ìã/1 ìë  │(Èíäèÿ)                       │21.06.95      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [S01BA04]           │âçâåñü ãëàçíàÿ 0.5%           │Polfa (Ïîëüøà)                │2613,         

                                                                                                                                                      │21.06.90,     

                                                                                                                                                      │23.11.79      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Polfa, Pabianickie Zaklady    │006142,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │06.06.95      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [D07AA03]           │ìàçü 0.5%                     │Polfa, Poznanskie Zaklady     │006601,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │28.11.95      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Rusan Pharma (Èíäèÿ)          │005144,       

                                                                                                                                                      │19.07.94      

                                                                                                                                                                    

│Ïðåäíèçîëîí [Ïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Wave International (Èíäèÿ)    │003118,       

                                                                                                                                                      │30.06.93      

                                                                                                                                                                    

│Ïðåäíèçîëîí Õàôñëóíä Íèêîìåä [Ïðåäíèçîëîí]        │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã; ðàñòâîð äëÿ    │Hafslund Nycomed Pharma AG    │003322,       

                                                                                          │èíúåêöèé (àìïóëû) 25 ìã - 1 ìë│(Àâñòðèÿ)                     │10.09.93      

                                                                                                                                                                    

│Ïðåäíèçîëîí-Ðèâîôàðì [Ïðåäíèçîëîí]                │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Rivopharm SA (Øâåéöàðèÿ)      │003854,       

                                                                                                                                                      │18.04.94      

                                                                                                                                                                    

│Ïðåäíèçîëîíà àöåòàò [Ïðåäíèçîëîí]                 │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │ñóñïåíçèÿ äëÿ èíúåêöèé        │Astrapin (Ãåðìàíèÿ)           │003646,        

                                                                                          │(àìïóëû) 25 ìã/ìë                                           │31.01.94      

                                                                                                                                                                    

│Ïðåäíèçîëîíà àöåòàò [Ïðåäíèçîëîí]                 │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │ñóñïåíçèÿ äëÿ èíúåêöèé        │Rotexmedica Osoo (Ãåðìàíèÿ)   │005502,        

                                                                                          │(àìïóëû) 25 ìã/ìë                                           │15.11.94      

                                                                                                                                                                    

│Ïðåäíîë [Ìåòèëïðåäíèçîëîí]                        │ãëþêîêîðòèêîñòåðîèä [H02AB04]           │òàáëåòêè 4, 16 ìã             │Mustafa Nevzat Ilac Sanayi AS │002564,       

                                                                                                                        │(Òóðöèÿ)                      │20.07.92      

                                                                                                                                                                    

│Ïðåäíîë-Ë [Ìåòèëïðåäíèçîëîí]                      │ãëþêîêîðòèêîñòåðîèä [H02AB04]           │ëèîôèëèç.ïîðîøîê äëÿ          │Mustafa Nevzat Ilac Sanayi AS │002253,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Òóðöèÿ)                      │14.10.91      

                                                                                          │ðàñòâîðà (àìïóëû) 20, 40, 250 │                                            

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Ïðåäóêòàë [Òðèìåòàçèäèí]                          │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DX17]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Servier (Ôðàíöèÿ)│005190,       

                                                                                          │20 ìã                                                       │28.07.94      

                                                                                                                                                                    

│Ïðåìàðèí [Ýñòðîãåíû êîíúþãèðîâàííûå]              │ýñòðîãåí [G03CA57]                      │òàáëåòêè 0.625, 1.25 ìã       │Wyeth Group (Âåëèêîáðèòàíèÿ)  │005163,       

                                                                                                                                                      │21.07.94      

                                                                                                                                                                    

│Ïðåíàöèä [Äåñîíèä]                                │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │êàïëè ãëàçíûå; ìàçü ãëàçíàÿ   │S.I.F.I. Spa (Èòàëèÿ)         │01925, 19.07.90│

                                                  │ïðèìåíåíèÿ [S01BA11]                                                                                              

                                                                                                                                                                    

│Ïðåïèäèë ãåëü [Äèíîïðîñòîí]                       │ðîäîâîé äåÿòåëüíîñòè ñòèìóëÿòîð         │ãåëü (øïðèö îäíîðàçîâûé) 0.5  │Upjohn (Áåëüãèÿ)              │003220,       

                                                  │[G02AD02]                               │ìã/3 ã                                                      │11.08.93      

                                                                                                                                                                    

│Ïðåñîìåí [Ýñòðîãåíû êîíúþãèðîâàííûå]              │ýñòðîãåí [G03CA57]                      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Kali-Chemie Pharma GmbH (ÔÐÃ) │002086,       

                                                                                          │1.25 ìã                                                     │21.03.91      

                                                                                                                                                                    

│Ïðåñîìåí [Ýñòðîãåíû êîíúþãèðîâàííûå] {ýñòðîãåíû   │ýñòðîãåí [G03CA57]                      │äðàæå 0.6 ìã; äðàæå           │Kali-Chemie Pharma GmbH (ÔÐÃ) │002144,       

│êîíüþãèðîâàííûå 0.125 ìã - 10 äðàæå, ýñòðîãåíû                                            │êîìïîçèòóì 0.6 ìã                                           │28.05.91      

│êîíüþãèðîâàííûå 0.125 ìã, ìåäðîãåñòîí 5 ìã - 10                                                                                                                     

│äðàæå}                                                                                                                                                              

                                                                                                                                                                    

│Ïðåñòàðèóì [Ïåðèíäîïðèë]                          │ÀÊÔ áëîêàòîð [C09AA04]                  │òàáëåòêè 4 ìã                 │Laboratoires Servier (Ôðàíöèÿ)│003026,       

                                                                                                                                                      │01.06.93      

                                                                                                                                                                    

│Ïðèâåíò [Êåòîòèôåí]                               │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã                 │Micro Labs Ltd (Èíäèÿ)        │007451,       

                                                                                                                                                      │17.04.96      

                                                                                                                                                                    

│Ïðèëåêñ [Öåôàëåêñèí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã           │Hindustan Antibiotics Ltd     │006027,       

                                                                                                                        │(Èíäèÿ)                       │04.05.95      

                                                                                                                                                                    

│Ïðèìàìåò [Öèìåòèäèí]                              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lek D.D. (Ñëîâåíèÿ)           │006490,       

                                                  │[A02BA01]                               │200 ìã; ðàñòâîð äëÿ èíúåêöèé                                │12.09.95      

                                                                                          │(àìïóëû) 200 ìã - 2 ìë                                                    

                                                                                                                                                                    

│Ïðèìîëþò-íîð [Íîðýòèñòåðîí]                       │ïðîãåñòàãåí [G03DC02]                   │òàáëåòêè 5, 10 ìã             │Schering AG (ÔÐÃ)             │003284,       

                                                                                                                                                      │30.08.93      

                                                                                                                                                                    

│Ïðèíèâèë [Ëèçèíîïðèë]                             │ÀÊÔ áëîêàòîð [C09AA03]                  │òàáëåòêè 5, 10, 20 ìã         │Merck Sharp & Dohme           │005411,       

                                                                                                                        │(Ãîëëàíäèÿ)                   │19.10.94      

                                                                                                                                                                    

│Ïðèíîðì [Àòåíîëîë]                                │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 100 ìã               │Galenika (ÑÔÐÞ)               │01885, 26.06.90│

                                                  │[C07AB03]                                                                                                         

                                                                                                                                                                    

│Ïðîáîí [Ðèìàçîëèé ìåòèëñóëüôàò]                   │àíàëüãåòè÷åñêîå ñðåäñòâî [N02BG02]      │äðàæå 300 ìã                  │Chinoin (Âåíãðèÿ)             │2386,         

                                                                                                                                                      │15.10.74,     

                                                                                                                                                      │15.10.91       

                                                                                                                                                                    

│Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè 100 ìã               │Eczacibasi (Òóðöèÿ)           │002993,       

                                                                                                                                                      │28.04.93       

                                                                                                                                                                    

│Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè 100 ìã               │Upjohn (Áåëüãèÿ)              │00869,        

                                                                                                                                                      │05.07.93,     

                                                                                                                                                      │29.07.81      

                                                                                                                                                                    

│Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè 250, 500 ìã          │Upjohn (Âåëèêîáðèòàíèÿ)       │002500,       

                                                                                                                                                      │04.06.92      

                                                                                                                                                                    

│Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè 250, 500 ìã          │Upjohn (ÑØÀ)                  │002500,       

                                                                                                                                                      │04.06.92      

                                                                                                                                                                    

│Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │ãðàíóëû 200, 500, 1000 ìã     │Upjohn (Èòàëèÿ)               │003741,       

                                                                                                                                                      │03.03.94      

                                                                                                                                                                    

│Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè 5 ìã, 10 ìã          │Upjohn (Áåëüãèÿ)              │005008,       

                                                                                                                                                      │16.06.94      

                                                                                                                                                                    

│Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè 100 ìã               │Upjohn (Èíäîíåçèÿ)            │005743,       

                                                                                                                                                      │14.02.95      

                                                                                                                                                                    

│Ïðîâèðîí [Ìåñòåðîëîí]                             │àíäðîãåí [G03BB01]                      │òàáëåòêè 25 ìã                │Schering AG (Ãåðìàíèÿ)        │003559,       

                                                                                                                                                      │07.12.93      

                                                                                                                                                                    

│Ïðîãèíîâà [Ýñòðàäèîë]                             │ýñòðîãåí [G03CA03]                      │äðàæå 2 ìã                    │Schering AG (ÔÐÃ)             │002933,       

                                                                                                                                                      │30.03.93      

                                                                                                                                                                    

│Ïðîäåï [Ôëóîêñåòèí]                               │àíòèäåïðåññàíò [N06AB03]                │êàïñóëû 20 ìã                 │Sun Pharmaceutical Industries │002959,       

                                                                                                                        │Ltd (Èíäèÿ)                   │12.04.93      

                                                                                                                                                                    

│Ïðîäåðì [Áåíçîèëà ïåðåêèñü]                       │àíòèñåïòè÷åñêîå ñðåäñòâî [D10AE01]      │êðåì (òóáû) 10%               │American Drug Company (ÑØÀ)   │006186,       

                                                                                                                                                      │14.06.95      

                                                                                                                                                                    

│Ïðîçàê [Ôëóîêñåòèí]                               │àíòèäåïðåññàíò [N06AB03]                │êàïñóëû 20 ìã                 │Eli Lilly & Elanco (ÑØÀ)      │002233,       

                                                                                                                                                      │26.08.91      

                                                                                                                                                                    

│Ïðîçîëèí [Öåôàçîëèí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Promed Exports Pvt Ltd (Èíäèÿ)│005264,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │24.08.94      

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                               

                                                                                                                                                                    

│Ïðîêàèí-Áåíçèëïåíèöèëëèí [Ïåíèöèëëèí ïðîêàèí]     │àíòèáèîòèê, ïåíèöèëëèí [J01CE09]        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Sanavita Gesundcheitsmittel & │006820,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Co Kg (Ãåðìàíèÿ)              │13.11.95      

                                                                                          │(ôëàêîíû) 1000000, 3000000,                                               

                                                                                          │4000000 ÅÄ                                                                

                                                                                                                                                                    

│Ïðîêîðóì [Ãàëëîïàìèë]                             │ÁÌÊÊ [C08DA02]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Knoll AG (Ãåðìàíèÿ)           │003479,       

                                                                                          │50 ìã                                                       │01.11.93      

                                                                                                                                                                    

│Ïðîêîðóì ðåòàðä [Ãàëëîïàìèë]                      │ÁÌÊÊ [C08DA02]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Knoll AG (Ãåðìàíèÿ)           │006786,       

                                                                                          │100 ìã                                                      │02.11.95      

                                                                                                                                                                    

│Ïðîêñàöèí [Öèïðîôëîêñàöèí]                        │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Fako Ilaclary AS (Òóðöèÿ)     │002606,       

                                                  │[J01MA02]                                                                                           │09.09.92      

                                                                                                                                                                    

│Ïðîêòî-ãëèâåíîë {òðèáåíîçèä 0.4 ã, ëèäîêàèí 40 ìã │ïðîòèâîãåìîððîèäàëüíîå ñðåäñòâî         │êðåì                          │Ciba-Geigy (Øâåéöàðèÿ)        │00362, 07.10.75│

│- ñâå÷à; òðèáåíîçèä 5%, ëèäîêàèí 2% - êðåì 1 ã}   │[C05AD03]                                                                                                          

                                                                                                                                                                    

│Ïðîêòî-ãëèâåíîë {òðèáåíîçèä 0.4 ã, ëèäîêàèí 40 ìã │ïðîòèâîãåìîððîèäàëüíîå ñðåäñòâî         │ñâå÷è                         │Ciba-Geigy (Øâåéöàðèÿ)        │00362,        

│- ñâå÷à; òðèáåíîçèä 5%, ëèäîêàèí 2% - êðåì 1 ã}   │[C05AD03]                                                                                           │07.10.75,      

                                                                                                                                                      │19.12.89      

                                                                                                                                                                    

│Ïðîêòîñåäèë {ôðàìèöåòèí 5 ìã, ãèäðîêîðòèçîí 2.79  │ïðîòèâîãåìîððîèäàëüíîå ñðåäñòâî         │ñâå÷è; ìàçü (òóáû) 15 ã       │Roussel Laboratories Ltd      │007433,       

│ìã, ýñêóëîñèä 5 ìã, ýòèëàìèíîáåíçîàò 5 ìã,        │[C05AA01]                                                             │(Âåëèêîáðèòàíèÿ)              │15.04.96      

│áóòèëàìèíîáåíçîàò 5 ìã - ñâå÷à; ôðàìèöåòèí 10 ìã, │                                                                                                                  

│ãèäðîêîðòèçîí 5.58 ìã, ýñêóëîñèä 10 ìã, ãåïàðèí                                                                                                                      

│100 ÅÄ, ýòèëàìèíîáåíçîàò 10 ìã, áóòèëàìèíîáåíçîàò │                                                                                                                  

│10 ìã - ìàçü 1 ã}                                                                                                                                                   

                                                                                                                                                                    

│Ïðîêòîñåäèë {ôðàìèöåòèí 5 ìã, ãèäðîêîðòèçîí 2.79  │ïðîòèâîãåìîððîèäàëüíîå ñðåäñòâî         │êàïñóëû ðåêòàëüíûå; ìàçü      │Roussel Uclaf (Èíäèÿ)         │002044,       

│ìã, ýñêóëîñèä 5 ìã, ýòèëàìèíîáåíçîàò 5 ìã,        │[C05AA01]                                                                                           │21.02.91      

│áóòèëàìèíîáåíçîàò 5 ìã - êàïñóëà; ôðàìèöåòèí 10                                                                                                                     

│ìã, ãèäðîêîðòèçîí 5.58 ìã - ìàçü 1 ã;                                                                                                                               

│ýòèëàìèíîáåíçîàò 10 ìã, áóòèëàìèíîáåíçîàò 10 ìã - │                                                                                                                  

│ñâå÷à}                                                                                                                                                              

                                                                                                                                                                    

│Ïðîëåéêèí [Àëäåñëåéêèí]                           │öèòîñòàòè÷åñêîå ñðåäñòâî [L03AA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Eurocetus Italy Spa (Èòàëèÿ)  │002409,       

                                                                                          │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │30.01.92      

                                                                                          │ðàñòâîðà 18000000 ÌÅ/ìë =1                                                

                                                                                          │ìã/ìë                                                                     

                                                                                                                                                                    

│Ïðîëåêñèí [Öåôàëåêñèí]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã; ïîðîøîê  │Promed Exports Pvt Ltd (Èíäèÿ)│005266,       

                                                                                          │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │24.08.94      

                                                                                          │ñóñïåíçèè 125 ìã|5 ìë                                                     

                                                                                                                                                                    

│Ïðîëèíàò [Ôëóôåíàçèí]                             │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB02]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Sun Pharmaceutical Industries │005769,       

                                                                                          │25 ìã/ìë                      │Ltd (Èíäèÿ)                   │22.02.95      

                                                                                                                                                                    

│Ïðîëèïàçà {ëèïàçà 4000 ÌÅ, àìèëàçà 2000 ÌÅ,       │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │êàïñóëû                       │Cilag International AG        │003214,       

│ïðîòåàçà 25000 ÌÅ}                                │[A09AA02]                                                             │(Øâåéöàðèÿ)                   │10.08.93      

                                                                                                                                                                    

│Ïðîëîë [Ïðîïðàíîëîë]                              │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 40 ìã                │Eipico (Åãèïåò)               │003985,       

                                                                                                                                                      │06.06.94      

                                                                                                                                                                    

│Ïðîìèò [Äåêñòðàí, ìîë.ìàññà îêîëî 1000] {äåêñòðàí │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [B05AA05] │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Kabi Pharmacia (Øâåöèÿ)       │003232,       

│1000 - 15 ã, íàòðèÿ õëîðèä 6 ìã}                                                          │150 ìã/ìë - 20 ìë                                           │16.08.93      

                                                                                                                                                                    

│Ïðîíàêñåí [Íàïðîêñåí]                             │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250, 500 ìã          │Orion Pharmaceutica           │003102,       

                                                                                                                        │(Ôèíëÿíäèÿ)                   │28.06.93      

                                                                                                                                                                    

│Ïðîíèöèä [Ýòèîíàìèä]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AD03] │òàáëåòêè 250 ìã               │Themis Chemicals Ltd (Èíäèÿ)  │002329,       

                                                                                                                                                      │14.01.92      

                                                                                                                                                                    

│Ïðîïàôåíîí ÎÔ 150 [Ïðîïàôåíîí]                    │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BC03]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ostpharm Arzneimittel GmbH &  │006534,       

                                                                                          │150 ìã                        │Co Kg (Ãåðìàíèÿ)              │21.09.95      

                                                                                                                                                                    

│Ïðîïàôåíîí ÎÔ 300 [Ïðîïàôåíîí]                    │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BC03]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ostpharm Arzneimittel GmbH &  │006535,       

                                                                                          │300 ìã                        │Co Kg (Ãåðìàíèÿ)              │21.09.95      

                                                                                                                                                                    

│Ïðîïèöèë [Ïðîïèëòèîóðàöèë]                        │àíòèòèðåîèäíîå ñðåäñòâî [H03BA02]       │òàáëåòêè 50 ìã                │Kali-Chemie Pharma GmbH       │007020,       

                                                                                                                        │(Ãåðìàíèÿ)                    │06.02.96      

                                                                                                                                                                    

│Ïðîïîëèí {ïðîïîëèñ}                               │ãåïàòîïðîòåêòîð [A05BA]                 │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │(Óêðàèíà)                     │93/59/3       

                                                                                                                                                                    

│Ïðîïðà-Ðàòèîôàðì [Ïðîïðàíîëîë]                    │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ratiopharm GmbH & Co          │005005,        

                                                                                          │10, 40, 80 ìã                 │(Ãåðìàíèÿ)                    │15.06.94      

                                                                                                                                                                    

│Ïðîïðàíîáåíå [Ïðîïðàíîëîë]                        │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Ludwig Merckle GmbH (Àâñòðèÿ) │003332,        

                                                                                          │îáîëî÷êîé 10, 40, 80 ìã                                     │13.09.93      

                                                                                                                                                                    

│Ïðîïðàíîáåíå [Ïðîïðàíîëîë]                        │áåòà-àäðåíîáëîêàòîð [C07AA05]           │êàïñóëû ðåòàðä 80, 160 ìã     │Ludwig Merckle GmbH (Àâñòðèÿ) │005683,       

                                                                                                                                                      │24.01.95      

                                                                                                                                                                    

│Ïðîïðàíîëîë [Ïðîïðàíîëîë]                         │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 40 ìã                │Weimer Pharma (Ãåðìàíèÿ)      │006851,       

                                                                                                                                                      │22.11.95      

                                                                                                                                                                    

│Ïðîïðàíîëîë Íèêîìåä [Ïðîïðàíîëîë]                 │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 10, 40, 80, 160 ìã   │Nycomed Dak AS (Äàíèÿ)        │006107,       

                                                                                                                                                      │25.05.95      

                                                                                                                                                                    

│Ïðîñåïòèí [Îìåïðàçîë]                             │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Beximco Pharmaceuticals Ltd   │006550,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                            │(Áàíãëàäåø)                   │25.09.95      

                                                                                                                                                                    

│Ïðîñêàð [Ôèíàñòåðèä]                              │àíòèàíäðîãåí [G04BX04]                  │òàáëåòêè 5 ìã                 │Merck Sharp & Dohme           │003106,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │29.06.93      

                                                                                                                                                                    

│Ïðîñêàð [Ôèíàñòåðèä]                              │àíòèàíäðîãåí [G04BX04]                  │òàáëåòêè 5 ìã                 │Merck Sharp & Dohme B.V.      │006910,       

                                                                                                                        │(Ãîëëàíäèÿ)                   │19.12.95      

                                                                                                                                                                    

│Ïðîñòàï [Ëåéïðîðåëèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L02AE02]      │ëèîôèëèç.ïîðîøîê äëÿ          │Takeda Chemical Industries    │003885,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Ltd (ßïîíèÿ)                  │28.04.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 3.75 ìã                                                

                                                                                                                                                                    

│Ïðîñòèí ÂÐ [Àëïðîñòàäèë]                          │âàçîäèëàòèðóþùåå ñðåäñòâî [C01EA01]     │ðàñòâîð äëÿ èíôóçèé (àìïóëû)  │Upjohn (Áåëüãèÿ)              │002431,       

                                                                                          │0.5 ìã - 1 ìë                                               │24.03.92      

                                                                                                                                                                    

│Ïðîñòèí ÂÐ [Àëïðîñòàäèë]                          │âàçîäèëàòèðóþùåå ñðåäñòâî [C01EA01]     │ðàñòâîð äëÿ èíúåêöèé äëÿ      │Upjohn (Áåëüãèÿ)              │003222,       

                                                                                          │äåòåé (àìïóëû) 0.5 ìã/ìë -                                  │11.08.93      

                                                                                          │0.2, 0.5 ìë                                                               

                                                                                                                                                                    

│Ïðîñòèí Å2 [Äèíîïðîñòîí]                          │ðîäîâîé äåÿòåëüíîñòè ñòèìóëÿòîð         │òàáëåòêè 0.5 ìã               │Upjohn (Áåëüãèÿ)              │00860,        

                                                  │[G02AD02]                                                                                           │12.07.93,     

                                                                                                                                                      │22.05.81      

                                                                                                                                                                    

│Ïðîñòèí Å2 [Äèíîïðîñòîí]                          │ðîäîâîé äåÿòåëüíîñòè ñòèìóëÿòîð         │ðàñòâîð äëÿ âíóòðèâåííîãî     │Upjohn (Áåëüãèÿ)              │003221,       

                                                  │[G02AD02]                               │ââåäåíèÿ (àìïóëû) 1 ìã/ìë -                                 │11.08.93      

                                                                                          │0.75 ìë; ðàñòâîð äëÿ èíúåêöèé │                                            

                                                                                          │(àìïóëû) 10 ìã/ìë - 0.5 ìë;                                               

                                                                                          │ðàñòâîð äëÿ                                                               

                                                                                          │ýêñòðààìíèîòè÷åñêîãî ââåäåíèÿ │                                            

                                                                                          │(àìïóëû) 10 ìã/ìë - 0.5 ìë /â │                                            

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                               

                                                                                          │ôëàêîíû 50 ìë/                                                            

                                                                                                                                                                    

│Ïðîñòèí Å2 [Äèíîïðîñòîí]                          │ðîäîâîé äåÿòåëüíîñòè ñòèìóëÿòîð         │ãåëü âàãèíàëüíûé (øïðèö       │Upjohn (Áåëüãèÿ)              │005526,       

                                                  │[G02AD02]                               │îäíîðàçîâûé) 1 ìã/3 ã, 2 ìã/3 │                              │25.11.94      

                                                                                          │ã                                                                         

                                                                                                                                                                    

│Ïðîñòèí Ô2-àëüôà [Äèíîïðîñò]                      │ðîäîâîé äåÿòåëüíîñòè ñòèìóëÿòîð         │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Upjohn (Áåëüãèÿ)              │00381,        

                                                  │[G02AD01]                               │5 ìã/ìë - 1, 4, 5, 8 ìë                                     │24.03.76,     

                                                                                                                                                      │25.03.87      

                                                                                                                                                                    

│Ïðîòàá {àëãåëäðàò 0.3 ã, ìàãíèÿ ãèäðîêñèä 0.3 ã,  │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè                      │Eczacibasi (Òóðöèÿ)           │003625,       

│ìåòèëïîëèêñèëîêñàí 20 ìã}                                                                                                                             │12.01.94       

                                                                                                                                                                    

│Ïðîòàìåò [Ìåòðîíèäàçîë]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250, 500 ìã          │Menon Pharma (Èíäèÿ)          │005605,       

                                                                                                                                                      │26.12.94       

                                                                                                                                                                    

│Ïðîòàìèí ñóëüôàò [Ïðîòàìèíà ñóëüôàò]              │ãåìîñòàòè÷åñêîå ñðåäñòâî [V03AB14]      │ðàñòâîð äëÿ âíóòðèâåííîãî     │ICN-Galenika (Þãîñëàâèÿ)      │006600,       

                                                                                          │ââåäåíèÿ (àìïóëû) 50 ìã - 5 ìë│                              │28.11.95      

                                                                                                                                                                    

│Ïðîòàôàí HM [Èíñóëèí-ÑðÄ] {èíñóëèí                │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ðàñòâîð äëÿ èíúåêöèé          │Novo Nordisk (Äàíèÿ)          │003064,       

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé}                                                            │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │16.06.93      

                                                                                                                                                                    

│Ïðîòàôàí HM ïåíôèëë [Èíñóëèí-ÑðÄ] {èíñóëèí        │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Novo Nordisk (Äàíèÿ)          │003269,       

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé}                                                            │(ãèëüçû ñòåêëÿííûå äëÿ                                      │26.08.93      

                                                                                          │øïðèöðó÷êè) 100 ÌÅ/ìë - 3 ìë                                              

                                                                                                                                                                    

│Ïðîòèâîàëëåðãè÷åñêèå êàïëè {íàòðèÿ õëîðèä, íàòðèÿ │îôòàëüìîëîãè÷åñêîå ñðåäñòâî [S01GX]     │êàïëè ãëàçíûå (ôëàêîíû)       │Bausch & Lomb (ÑØÀ)           │006724,       

│áîðàò, áîðíàÿ êèñëîòà, ïîëèýòèëåíãëèêîëü,                                                                                                             │18.10.95      

│íàôàçîëèí, áåíçàëêîíèé}                                                                                                                                             

                                                                                                                                                                    

│Ïðîòèîíàìèä [Ïðîòèîíàìèä]                         │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AD01] │äðàæå 250 ìã                  │Gedeon Richter (Âåíãðèÿ)      │2652,         

                                                                                                                                                      │09.12.80,     

                                                                                                                                                      │25.01.93      

                                                                                                                                                                    

│Ïðîôàçè [Ãîíàäîòðîïèí õîðèîíè÷åñêèé]              │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Ares-Serono Group (Øâåéöàðèÿ) │01864, 01.06.90│

                                                  │[G03GA01]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (àìïóëû) 500, 1000,                                              

                                                                                          │1500, 2000, 5000 ÌÅ /â                                                    

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ïðîôåí [Èáóïðîôåí]                                │ÍÏÂÑ [M02AA13]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Panacea Biotec Ltd (Èíäèÿ)    │005639,       

                                                                                          │200, 400 ìã                                                 │11.01.95      

                                                                                                                                                                    

│Ïðîôåíàí [Ïðîïàôåíîí]                             │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BC03]     │ðàñòâîð äëÿ âíóòðèâåííîãî     │Slaviamed (Þãîñëàâèÿ)         │007560,       

                                                                                          │ââåäåíèÿ (àìïóëû) 35 ìã/10                                  │03.06.96      

                                                                                          │ìë; òàáëåòêè ïîêðûòûå                                                     

                                                                                          │îáîëî÷êîé 150, 300 ìã                                                     

                                                                                                                                                                    

│Ïðîôåíèä [Êåòîïðîôåí]                             │ÍÏÂÑ [M01AE03]                          │êàïñóëû 50 ìã; ñâå÷è 100 ìã;  │Rhone-Poulenc Rorer (Ôðàíöèÿ) │006320,       

                                                                                          │ëèîôèëèç.ïîðîøîê äëÿ                                        │26.07.95      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà 100 ìã /â êîìïëåêòå                                              

                                                                                          │ñ ðàñòâîðèòåëåì/                                                          

                                                                                                                                                                    

│Ïðîôåíèä ãåëü 2.5% [Êåòîïðîôåí]                   │ÍÏÂÑ [M02AA10]                          │ãåëü (òóáû) 2.5% - 60 ã       │Rhone-Poulenc Rorer (Ôðàíöèÿ) │007466,       

                                                                                                                                                      │23.04.96      

                                                                                                                                                                    

│Ïðîôèëàð [Êåòîòèôåí]                              │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã                 │United Pharmaceutical         │002948,       

                                                                                                                        │Manufactoring Co Ltd          │31.03.93      

                                                                                                                        │(Èîðäàíèÿ)                                  

                                                                                                                                                                    

│Ïñîðàêñ [Äèòðàíîë]                                │öèòîñòàòè÷åñêîå ñðåäñòâî [D05AC01]      │êðåì; êðåì ôîðòå              │Kurtsan Ilaclary AS (Òóðöèÿ)  │002895,       

                                                                                                                                                      │10.03.93      

                                                                                                                                                                    

│Ïñîðêóòàí [Êàëüöèïîòðèîë]                         │ïðîòèâîïñîðèàòè÷åñêîå ñðåäñòâî [D05AX02]│ìàçü (òóáû) 0.005%            │Schering AG (Ãåðìàíèÿ)        │005093,       

                                                                                                                                                      │06.07.94      

                                                                                                                                                                    

│Ïóëüìèêîðò [Áóäåñîíèä]                            │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │ñóñïåíçèÿ 50 ìêã|äîçà         │Astra (Øâåöèÿ)                │002743,       

                                                  │ïðèìåíåíèÿ [R03BA02]                    │(àýðîçîëüíûå áàëëîíû) 1 ìã/ìë │                              │11.12.92      

                                                                                          │- 200 äîç; ñóñïåíçèÿ 200                                                   

                                                                                          │ìêã|äîçà (àýðîçîëüíûå                                                     

                                                                                          │áàëëîíû) 4 ìã/ìë - 100 äîç                                                

                                                                                                                                                                     

│Ïóëüìèêîðò òóðáóõàëåð [Áóäåñîíèä]                 │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │ïîðîøîê äëÿ èíãàëÿöèé 200     │Astra (Øâåöèÿ)                │006135,       

                                                  │ïðèìåíåíèÿ [R03BA02]                    │ìêã|äîçà (òóðáóõàëåðû) 100,                                 │01.06.95      

                                                                                          │200 äîç                                                                    

                                                                                                                                                                    

│Ïóëüñíîðìà {àéìàëèí 30 ìã, ñïàðòåèí 25 ìã,        │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BG]       │òàáëåòêè                      │Giulini Pharma GmbH (ÔÐÃ)     │01958, 07.09.90│

│àíòàçîëèí 50 ìã, ôåíîáàðáèòàë 5 ìã}                                                                                                                                  

                                                                                                                                                                    

│Ïóðè-íåòîë [Ìåðêàïòîïóðèí]                        │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BB02]      │òàáëåòêè 50 ìã                │Wellcome Foundation Ltd       │003337,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │17.09.93      

                                                                                                                                                                    

│Ïóðèíîë [Àëëîïóðèíîë]                             │êñàíòèíîêñèäàçû èíãèáèòîð [M04AA01]     │òàáëåòêè 100, 300 ìã          │Ludwig Merckle GmbH (Àâñòðèÿ) │002985,       

                                                                                                                                                      │27.04.93      

                                                                                                                                                                    

│ÏÝÃ-Ë-àñïàðàãèíàçà (Îíêàñïàð) [Àñïàðàãèíàçà]      │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XX02]      │ðàñòâîð äëÿ èíúåêöèé          │Enson (ÑØÀ)                   │002628,       

                                                                                          │(ôëàêîíû) 3750 ÌÅ - 5 ìë                                    │15.09.92      

                                                                                                                                                                    

│Ð-öèí [Ðèôàìïèöèí]                                │àíòèáèîòèê [J04AB02]                    │êàïñóëû 150, 300, 450, 600 ìã │Lupin Laboratories Ltd (Èíäèÿ)│002928,       

                                                                                                                                                      │30.03.93      

                                                                                                                                                                    

│Ðàâåðîí {ýêñòðàêò ïðîñòàòû}                       │áèîñòèìóëèðóþùåå ñðåäñòâî [G04BX]       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Robapharm AG (Øâåéöàðèÿ)      │00328,        

                                                                                          │1 ìë                                                        │22.01.93,     

                                                                                                                                                      │31.01.75      

                                                                                                                                                                    

│Ðàäåäîðì [Íèòðàçåïàì]                             │òðàíêâèëèçàòîð [N05CD02]                │òàáëåòêè 5 ìã                 │Arzneimittelwerk Dresden GmbH │00122,        

                                                                                                                        │(Ãåðìàíèÿ)                    │01.06.94,     

                                                                                                                                                      │18.05.84,     

                                                                                                                                                      │19.03.71      

                                                                                                                                                                    

│Ðàäåíàðêîí [Ýòîìèäàò]                             │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Arzneimittelwerk Dresden Feb  │01421, 17.03.88│

                                                  │[N01AX07]                               │20 ìã - 10 ìë                 │(ÃÄÐ)                                       

                                                                                                                                                                    

│Ðàäåïóð 10 [Õëîðäèàçåïîêñèä]                      │òðàíêâèëèçàòîð [N05BA02]                │äðàæå 10 ìã                   │Arzneimittelwerk Dresden GmbH │006382,       

                                                                                                                        │(Ãåðìàíèÿ)                    │09.08.95      

                                                                                                                                                                    

│Ðàëîôåêò [Ïåíòîêñèôèëëèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè 200 ìã               │Arzneimittelwerk Dresden GmbH │002436,       

                                                                                                                        │(ÔÐÃ)                         │25.03.92      

                                                                                                                                                                    

│Ðàëîôåêò [Ïåíòîêñèôèëëèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè ðåòàðä 600 ìã;       │Arzneimittelwerk Dresden GmbH │006004,       

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │(Ãåðìàíèÿ)                    │26.04.95      

                                                                                          │100 ìã - 5 ìë                                                             

                                                                                                                                                                    

│Ðàëîôåêò 300 Í [Ïåíòîêñèôèëëèí]                   │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Arzneimittelwerk Dresden GmbH │006003,       

                                                                                          │èíôóçèîííîãî ðàñòâîðà         │(Ãåðìàíèÿ)                    │26.04.95      

                                                                                          │(àìïóëû) 300 ìã - 15 ìë                                                   

                                                                                                                                                                    

│Ðàìèïðèë [Ðàìèïðèë]                               │ÀÊÔ áëîêàòîð [C09AA05]                  │êàïñóëû 2.5, 5, 10 ìã         │Hoechst AG (ÔÐÃ)              │002177,       

                                                                                                                                                      │05.07.91      

                                                                                                                                                                    

│Ðàìîíîâàÿ ìàçü                                    │ïðîòèâîïñîðèàòè÷åñêîå ñðåäñòâî [D05A]   │ìàçü (òóáû) 2% - 50 ã; ìàçü   │(Êàçàõñòàí)                   │94/158/9      

                                                                                          │(áàíêè) 2% - 40 ã                                                         

                                                                                                                                                                    

│Ðàíèáåðë [Ðàíèòèäèí]                              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Berlin-Chemie AG (Ãåðìàíèÿ)   │005563,       

                                                  │[A02BA02]                               │168 ìã                                                      │14.12.94      

                                                                                                                                                                    

│Ðàíèãàñò [Ðàíèòèäèí]                              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa (Ïîëüøà)                │003065,        

                                                  │[A02BA02]                               │150 ìã                                                      │16.06.93      

                                                                                                                                                                    

│Ðàíèñàí [Ðàíèòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150 ìã               │Pro.Med.Cs (×ÑÔÐ)             │002682,        

                                                  │[A02BA02]                                                                                           │04.11.92      

                                                                                                                                                                    

│Ðàíèñàí [Ðàíèòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150 ìã; ðàñòâîð äëÿ  │Zdravle (Þãîñëàâèÿ)           │007258,       

                                                  │[A02BA02]                               │èíúåêöèé (àìïóëû) 50 ìã|5 ìë                                │16.07.96      

                                                                                                                                                                    

│Ðàíèòàá [Ðàíèòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Deva Holding AS (Òóðöèÿ)      │003469,       

                                                  │[A02BA02]                               │îáîëî÷êîé 150 ìã                                            │29.10.93      

                                                                                                                                                                    

│Ðàíèòàë [Ðàíèòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ôèëìòàáëåòêè 150, 300 ìã;     │Lek D.D. (Ñëîâåíèÿ)           │007386,       

                                                  │[A02BA02]                               │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                              │02.04.96      

                                                                                          │50 ìã - 2 ìë                                                              

                                                                                                                                                                    

│Ðàíèòàðä [Ðàíèòèäèí]                              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │M.J.Pharmaceuticals Ltd       │006340,       

                                                  │[A02BA02]                               │150, 300 ìã                   │(Èíäèÿ)                       │02.08.95      

                                                                                                                                                                    

│Ðàíèòèäèí [Ðàíèòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │J.R.Sharma Overseas Ltd       │003584,       

                                                  │[A02BA02]                               │50 ìã - 2 ìë                  │(Èíäèÿ)                       │14.12.93      

                                                                                                                                                                    

│Ðàíèòèäèí [Ðàíèòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150 ìã               │Pharmachim (Áîëãàðèÿ)         │003442,       

                                                  │[A02BA02]                                                                                           │22.10.93      

                                                                                                                                                                    

│Ðàíèòèäèí [Ðàíèòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150, 300 ìã; ðàñòâîð │Wave International (Èíäèÿ)    │003538,       

                                                  │[A02BA02]                               │äëÿ èíúåêöèé (àìïóëû) 50 ìã - │                              │03.12.93      

                                                                                          │2 ìë                                                                      

                                                                                                                                                                    

│Ðàíèòèí [Ðàíèòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Torrent Exports Ltd (Èíäèÿ)   │01976, 03.10.90│

                                                  │[A02BA02]                               │2 ìë                                                                      

                                                                                                                                                                    

│Ðàíèòèí [Ðàíèòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150, 300 ìã          │Torrent Laboratories Ltd      │01873, 19.06.90│

                                                  │[A02BA02]                                                             │(Èíäèÿ)                                     

                                                                                                                                                                    

│Ðàíêîòðèì [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë 400  │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 480, 960 ìã          │Ranbaxy Laboratories Ltd      │005998,       

│ìã, òðèìåòîïðèì 80 ìã; ñóëüôàìåòîêñàçîë 800 ìã,   │ñðåäñòâî [J01EE01]                                                    │(Èíäèÿ)                       │26.04.95      

│òðèìåòîïðèì 160 ìã}                                                                                                                                                 

                                                                                                                                                                    

│Ðàíîêñèë [Àìîêñèöèëëèí]                           │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Ranbaxy Laboratories Ltd      │007695,       

                                                  │[J01CA04]                               │îðàëüíîé ñóñïåíçèè (ôëàêîíû)  │(Èíäèÿ)                       │26.07.96      

                                                                                          │125 ìã|5 ìë, 250 ìã|5 ìë -                                                

                                                                                          │60, 100 ìë                                                                

                                                                                                                                                                    

│Ðàíòàê [Ðàíèòèäèí]                                │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150, 300 ìã          │Unique Pharmaceutical         │003493,       

                                                  │[A02BA02]                                                             │Laboratories (Èíäèÿ)          │04.11.93      

                                                                                                                                                                    

│Ðàíòàê [Ðàíèòèäèí]                                │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Unique Pharmaceutical         │003830,       

                                                  │[A02BA02]                               │25 ìã/ìë                      │Laboratories (Èíäèÿ)          │05.04.94      

                                                                                                                                                                    

│Ðàïèäàë [Òåðôåíàäèí]                              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 60 ìã                │Ifidesa-Aristegui (Èñïàíèÿ)   │003037,       

                                                  │[R06AX12]                                                                                           │07.06.93      

                                                                                                                                                                    

│Ðàñòâîð àíòèêîàãóëÿíòà ÖÔÄÀ-1 {ëèìîííàÿ êèñëîòà   │àíòèêîàãóëÿíò ïðÿìîé [B01A]             │ðàñòâîð (êîíòåéíåðû           │Amerid Ltd (Íåâèñ)            │007613,       

│299 ìã, íàòðèÿ öèòðàò äèãèäðàò 2.63 ìã, íàòðèÿ                                            │ïëàñòèêîâûå) 63 ìë/500 ìë, 58 │                              │28.06.96      

│ôîñôàò 222 ìã, äåêñòðîçà ãèäðàò 3.19 ìã, àäåíèí                                           │ìë/400 ìë                                                                 

│27.5 ìã - 100 ìë}                                                                                                                                                   

                                                                                                                                                                    

│Ðàñòâîð àíòèêîàãóëÿíòà ÖÔÄÀ-1                     │ãåìîêîíñåðâàíò [B01A]                   │ðàñòâîð (êîíòåéíåðû           │Baxter (ÑØÀ)                  │006906,        

│{öèòðàòíî-ôîñôàòíî-äåêñòðîçíî-àäåíèíîâûé ðàñòâîð} │                                        │ïëàñòèêîâûå) 250, 450, 500 ìë │                              │19.12.95      

                                                                                                                                                                    

│Ðàñòâîð àíòèêîàãóëÿíòà ÖÔÄÀ-1 {ëèìîííàÿ êèñëîòà   │àíòèêîàãóëÿíò ïðÿìîé [B01A]             │ðàñòâîð ãåìîêîíñåðâàíòà       │Green Cross Medical Corp.     │007496,        

│299 ìã, íàòðèÿ öèòðàò äèãèäðàò 2.63 ìã, íàòðèÿ                                            │(êîíòåéíåðû ïëàñòèêîâûå) 35   │(Êîðåÿ Þæíàÿ)                 │14.05.96      

│ôîñôàò 222 ìã, äåêñòðîçà ãèäðàò 3.19 ìã, àäåíèí                                           │ìë/250 ìë, 49 ìë/350 ìë, 63                                               

│27.5 ìã - 100 ìë}                                                                         │ìë/450 ìë, 70 ìë/500 ìë                                                    

                                                                                                                                                                    

│Ðàñòâîð àíòèêîàãóëÿíòà ÖÔÄÀ-1 {ëèìîííàÿ êèñëîòà   │àíòèêîàãóëÿíò ïðÿìîé [B01A]             │ðàñòâîð ãåìîêîíñåðâàíòà       │Terumo Corp. (ßïîíèÿ)         │007494,       

│299 ìã, íàòðèÿ öèòðàò äèãèäðàò 2.63 ìã, íàòðèÿ                                            │(êîíòåéíåðû ïëàñòèêîâûå) 35                                 │12.05.96      

│ôîñôàò 222 ìã, äåêñòðîçà ãèäðàò 3.19 ìã, àäåíèí                                           │ìë/250 ìë, 63 ìë/450 ìë, 70                                               

│27.5 ìã - 100 ìë}                                                                         │ìë/500 ìë                                                                 

                                                                                                                                                                    

│Ðàñòâîð Ãëþêîçû 10% [Äåêñòðîçà]                   │ïëàçìîçàìåùàþùåå ñðåäñòâî [V06DC01]     │ðàñòâîð äëÿ âíóòðèâåííîãî     │Polfa, Kutnowskie Zaklady     │007586,       

                                                                                          │ââåäåíèÿ (ôëàêîíû) 10% - 500  │Farmaceutyczne SA (Ïîëüøà)    │14.06.96      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ðàñòâîð ãëþêîçû 5% äëÿ èíúåêöèé [Äåêñòðîçà]       │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû  │Polfa, Kutnowskie Zaklady     │2786,         

                                                  │[V06DC01]                               │èç ïîëèýòèëåíà) 5% - 500 ìë   │Farmaceutyczne SA (Ïîëüøà)    │12.10.84,     

                                                                                                                                                      │18.07.95      

                                                                                                                                                                    

│Ðàñòâîð ãëþêîçû 5% äëÿ èíúåêöèé [Äåêñòðîçà]       │ïëàçìîçàìåùàþùåå ñðåäñòâî [V06DC01]     │ðàñòâîð (ôëàêîíû èç           │Polfa, Lubelskie Zaklady      │006582,       

                                                                                          │ïîëèýòèëåíà) 5% - 500 ìë      │Farmaceutyczne SA (Ïîëüøà)    │13.10.95      

                                                                                                                                                                    

│Ðàñòâîð íàòðèÿ õëîðèäà èçîòîíè÷åñêèé 0.9% äëÿ     │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû  │Polfa, Kutnowskie Zaklady     │2787,         

│èíúåêöèé [Íàòðèÿ õëîðèä]                                                                  │èç ïîëèýòèëåíà) 0.9% - 500 ìë │Farmaceutyczne SA (Ïîëüøà)    │12.10.84,     

                                                                                                                                                      │18.07.95      

                                                                                                                                                                    

│Ðàñòâîð íàòðèÿ õëîðèäà èçîòîíè÷åñêèé 0.9% äëÿ     │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð (ôëàêîíû èç           │Polfa, Lubelskie Zaklady      │006583,       

│èíúåêöèé [Íàòðèÿ õëîðèä]                                                                  │ïîëèýòèëåíà) 0.9% - 500 ìë    │Farmaceutyczne SA (Ïîëüøà)    │13.10.95      

                                                                                                                                                                    

│Ðàñòâîð Íàòðèÿ õëîðèäà 0.9% è 5% Ãëþêîçû äëÿ      │ðåãèäðàòèðóþùåå ñðåäñòâî [B05BB]        │ðàñòâîð (áóòûëè               │Gulf Inject L.L.C.            │007475,       

│âíóòðèâåííûõ âëèâàíèé                                                                     │ïîëèýòèëåíîâûå) 500 ìë        │(Îáúåäèíåííûå Àðàáñêèå        │26.04.96      

                                                                                                                        │Ýìèðàòû)                                    

                                                                                                                                                                    

│Ðàñòâîð Õàðòìàííà {íàòðèÿ õëîðèä 7 ã, êàëüöèÿ     │ðåãèäðàòèðóþùåå ñðåäñòâî [B05XA30]      │ðàñòâîð äëÿ èíôóçèé (ìåøêè    │Eurocetus (Íèäåðëàíäû)        │007071,       

│õëîðèä 0.2 ã, êàëèÿ õëîðèä 0.4 ã, íàòðèÿ ëàêòàò 3 │                                        │ÏÂÕ) 500 ìë                                                 │08.02.96      

│ã, íàòðèé 146.4 ììîëü, êàëèé 5.4 ììîëü, êàëüöèé                                                                                                                     

│1.8 ììîëü, õëîð 128.8 ììîëü, ëàêòàò 26.8 ììîëü -                                                                                                                    

│1 ë}                                                                                                                                                                

                                                                                                                                                                    

│Ðàñòâîð Öèòðàòà íàòðèÿ 4% [Íàòðèÿ öèòðàò]         │ãåìîêîíñåðâàíò [B05CB02]                │ðàñòâîð (êîíòåéíåðû           │Baxter (ÑØÀ)                  │006905,       

                                                                                          │ïëàñòèêîâûå) 4% - 500, 600 ìë │                              │19.12.95      

                                                                                                                                                                    

│Ðàñòîöèí [Äîêñîðóáèöèí]                           │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DB01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Pliva (Õîðâàòèÿ)              │002618,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │10.09.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 10 ìã                                                  

                                                                                                                                                                    

│Ðåàáàí [Àòòàïóëãèò] {àëþìèíèÿ ñèëèêàò, ìàãíèÿ     │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07BC04]     │òàáëåòêè 750 ìã               │Pfizer Overseas Inc (ÑØÀ)     │002862,       

│ñèëèêàò}                                                                                                                                              │22.02.93      

                                                                                                                                                                    

│Ðåàëüäèðîí [Èíòåðôåðîí àëüôà]                     │èììóíîñòèìóëÿòîð [L03AA04]              │ëèîôèëèç.ïîðîøîê äëÿ          │Biofa (Ëèòâà)                 │006726,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │19.10.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1000000,                                               

                                                                                          │3000000, 6000000 ÌÅ;                                                      

                                                                                          │ëèîôèëèç.ïîðîøîê äëÿ                                                      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (àìïóëû) 1000000,                                                

                                                                                          │3000000, 6000000 ÌÅ                                                        

                                                                                                                                                                    

│Ðåâìàâåê [Äèêëîôåíàê]                             │ÍÏÂÑ [M01AB05]                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Faran Laboratories SA (Ãðåöèÿ)│003662,       

                                                                                          │75 ìã - 3 ìë                                                │01.02.94       

                                                                                                                                                                    

│Ðåâìîí ãåëü [Ýòîôåíàìàò]                          │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî äëÿ      │ãåëü (òóáû) 5% - 50 ã         │Bayer AG (Ãåðìàíèÿ)           │007222,       

                                                  │ìåñòíîãî ïðèìåíåíèÿ [M02AA06]                                                                       │24.06.96      

                                                                                                                                                                    

│Ðåâîäèíà 25 [Äèêëîôåíàê]                          │ÍÏÂÑ [M01AB05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Arzneimittelwerk Dresden GmbH │01422,        

                                                                                          │25 ìã                         │(Ãåðìàíèÿ)                    │17.03.88,     

                                                                                                                                                      │25.11.94      

                                                                                                                                                                    

│Ðåâîäèíà 50 [Äèêëîôåíàê]                          │ÍÏÂÑ [M01AB05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Arzneimittelwerk Dresden GmbH │005596,       

                                                                                          │50 ìã                         │(Ãåðìàíèÿ)                    │26.12.94      

                                                                                                                                                                    

│Ðåâîäèíà 75 ÑÔ [Äèêëîôåíàê]                       │ÍÏÂÑ [M01AB05]                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Arzneimittelwerk Dresden GmbH │003956,       

                                                                                          │75 ìã - 3 ìë                  │(Ãåðìàíèÿ)                    │30.05.94      

                                                                                                                                                                    

│Ðåâîäèíà ðåòàðä [Äèêëîôåíàê]                      │ÍÏÂÑ [M01AB05]                          │òàáëåòêè ðåòàðä 100 ìã        │Arzneimittelwerk Dresden GmbH │002852,       

                                                                                                                        │(ÔÐÃ)                         │16.02.93      

                                                                                                                                                                    

│Ðåãåéí [Ìèíîêñèäèë]                               │âàçîäèëàòèðóþùåå ñðåäñòâî [C02DC01]     │ðàñòâîð äëÿ íàðóæíîãî         │Upjohn (Áåëüãèÿ)              │007196,       

                                                                                          │ïðèìåíåíèÿ (ôëàêîíû) 2% - 60                                │23.05.96      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ðåãèäðîí {íàòðèÿ õëîðèä 3.5 ã, íàòðèÿ öèòðàò 2.9  │ðåãèäðàòèðóþùåå ñðåäñòâî [A07CA]        │ïîðîøîê äîçèðîâàííûé          │Orion Pharmaceutica           │01300, 24.10.86│

│ã, êàëèÿ õëîðèä 2.5 ã, ãëþêîçà 10}                                                                                      │(Ôèíëÿíäèÿ)                                 

                                                                                                                                                                    

│Ðåãèíèöèä [Ïðîòèîíàìèä]                           │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AD01] │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Themis Chemicals Ltd (Èíäèÿ)  │002330,       

                                                                                          │îáîëî÷êîé 250 ìã                                            │14.01.92      

                                                                                                                                                                    

│Ðåãèòèí [Ôåíòîëàìèí]                              │àëüôà-àäðåíîáëîêàòîð [C04AB01]          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ciba-Geigy (Øâåéöàðèÿ)        │002070,       

                                                                                          │10 ìã/1 ìë, 50 ìã/5 ìë                                      │14.03.91      

                                                                                                                                                                    

│Ðåãëà ÏÕ {àëþìèíèÿ îêñèä 460 ìã, ìàãíèÿ îêñèä 220 │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè; ãðàíóëû (ïàêåòèêè)  │Ucb Pharma (Áåëüãèÿ)          │006869,       

│ìã, àëãåëäðàò 360 ìã, ìàãíèÿ êàðáîíàò 360 ìã -                                            │5 ã                                                         │01.12.95      

│òàáëåòêà; àëþìèíèÿ îêñèä 920 ìã, ìàãíèÿ îêñèä 440 │                                                                                                                  

│ìã, àëãåëäðàò 720 ìã, ìàãíèÿ êàðáîíàò 720 ìã -                                                                                                                      

│ïàêåòèê}                                                                                                                                                            

                                                                                                                                                                    

│Ðåãëàí [Ìåòîêëîïðàìèä]                            │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Laboratoires Delagrange,      │005203,       

                                                                                          │5 ìã/ìë - 2 ìë; òàáëåòêè 10   │Laboratoires Synthelabo       │02.08.94      

                                                                                          │ìã; ðàñòâîð îðàëüíûé          │(Ôðàíöèÿ)                                   

                                                                                          │(ôëàêîíû) 0.1%                                                            

                                                                                                                                                                    

│Ðåãóëàð Èëåòèí II [Èíñóëèí-ÁÄ] {èíñóëèí           │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Eli Lilly & Elanco (ÑØÀ)      │02035, 28.12.90│

│íåéòðàëüíûé, ìîíîêîìïîíåíòíûé ñâèíîé}                                                     │(ôëàêîíû) 10 ìë - 40, 100                                                 

                                                                                          │ÅÄ/ìë                                                                     

                                                                                                                                                                    

│Ðåãóëèï [Ãåìôèáðîçèë]                             │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AC04]   │êàïñóëû 300 ìã                │Amoun Pharmaceutical          │006243,       

                                                                                                                        │Industries Co, Apic (Åãèïåò)  │03.07.95      

                                                                                                                                                                    

│Ðåãóëüòîí [Àìåçèíèé ìåòèëñóëüôàò]                 │âàçîêîíñòðèêòîðíîå ñðåäñòâî [C01C]      │òàáëåòêè                      │Knoll AG (ÔÐÃ)                │01719, 12.01.90│

                                                                                                                                                                    

│Ðåäåðãèí [Äèãèäðîýðãîòîêñèí] {äèãèäðîýðãîêðèñòèí  │àëüôà-àäðåíîáëîêàòîð [C04AE]            │òàáëåòêè 1.5 ìã; êàïëè 1 ìã/1 │Lek (Ñëîâåíèÿ)                │00987,        

│0.5 ìã, äèãèäðîýðãîêðèïòèí 0.5 ìã,                                                        │ìë; ðàñòâîð äëÿ èíúåêöèé                                    │07.02.83,     

│äèãèäðîýðãîêîðíèí 0.5 ìã}                                                                 │(àìïóëû) 0.3 ìã/1 ìë                                        │27.12.94      

                                                                                                                                                                    

│Ðåçåðïèí [Ðåçåðïèí] {ðàóâîëüôèè àëêàëîèä}         │ñèìïàòîëèòè÷åñêîå ñðåäñòâî [C02AA02]    │òàáëåòêè 0.1, 0.25 ìã         │Polfa (Ïîëüøà)                │2193,          

                                                                                                                                                      │02.10.70,     

                                                                                                                                                      │28.04.84      

                                                                                                                                                                     

│Ðåçèáåëàêòà [Öåôîòàêñèì]                          │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Laboratories Atral SA         │002991,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Ïîðòóãàëèÿ)                  │28.04.93      

                                                                                          │(ôëàêîíû) 1 ã /â êîìïëåêòå ñ                                               

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Ðåêîãíàí Å [Öèòèêîëèí]                            │íîîòðîïíîå ñðåäñòâî [N06BX06]           │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Toyo Jozo Co Ltd (ßïîíèÿ)     │01370, 31.08.87│

                                                                                          │1 ã - 8 ìë                                                                

                                                                                                                                                                    

│Ðåêîðìîí [Ýïîýòèí áåòà]                           │ãåìîïîýçà ñòèìóëÿòîð [B03XA01]          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Boehringer Mannheim GmbH      │002221,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Àâñòðèÿ)                     │20.08.91      

                                                                                          │(àìïóëû) 1000, 2000, 5000 ÌÅ                                              

                                                                                                                                                                    

│Ðåëàäîðì {öèêëîáàðáèòàë 0.1 ã, äèàçåïàì 10 ìã}    │ñíîòâîðíîå ñðåäñòâî [N05CB02]           │òàáëåòêè                      │Polfa (Ïîëüøà)                │2625,         

                                                                                                                                                      │09.03.93,     

                                                                                                                                                      │15.05.80      

                                                                                                                                                                    

│Ðåëàíèóì [Äèàçåïàì]                               │òðàíêâèëèçàòîð [N05BA01]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa (Ïîëüøà)                │2587,         

                                                                                          │10 ìã - 2 ìë                                                │05.06.90,     

                                                                                                                                                      │25.10.78      

                                                                                                                                                                    

│Ðåëàíèóì [Äèàçåïàì]                               │òðàíêâèëèçàòîð [N05BA01]                │òàáëåòêè 5 ìã                 │Polfa, Tarchominskie Zaklady  │006603,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │14.12.95      

                                                                                                                                                                    

│Ðåëàôåí [Íàáóìåòîí]                               │ÍÏÂÑ [M01AX01]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Smithkline Beecham            │006555,       

                                                                                          │500, 750 ìã                   │Pharmaceuticals (ÑØÀ)         │27.09.95      

                                                                                                                                                                    

│Ðåëñèäðåêñ-à {äèãèäðàëàçèí 10 ìã, ðåçåðïèí 0.1    │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │òàáëåòêè                      │Rusan Pharma (Èíäèÿ)          │005335,       

│ìã, ãèäðîõëîðîòèàçèä 10 ìã}                       │[C02LA51]                                                                                           │20.09.94      

                                                                                                                                                                    

│Ðåìàãåëü {àëãåëäðàò 0.3 ã, ìàãíèÿ ãèäðîêñèä 0.1   │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ îðàëüíàÿ            │Rehise Inc (ÑØÀ)              │003370,       

│ã, ñîðáèòîë 0.8 ã - 5 ìë}                                                                                                                             │05.10.93      

                                                                                                                                                                    

│Ðåìàãåëü À {àëãåëäðàò 0.3 ã, ìàãíèÿ ãèäðîêñèä 0.1 │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ îðàëüíàÿ            │Rehise Inc (ÑØÀ)              │003371,       

│ã, ñîðáèòîë 0.8 ã, áåíçîêàèí 0.1 ã - 5 ìë}                                                                                                            │05.10.93      

                                                                                                                                                                    

│Ðåìåñòèï [Òåðëèïðåññèí]                           │âàçîêîíñòðèêòîðíîå ñðåäñòâî [H01BA04]   │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lechiva (×åõèÿ)               │003460,       

                                                                                          │2 ìë                                                        │27.10.93      

                                                                                                                                                                    

│Ðåìåòàí [Äèêëîôåíàê]                              │ÍÏÂÑ [M01AB05]                          │òàáëåòêè ïîêðûòûå             │Remedica Ltd - Minnex (Êèïð)  │006811,       

                                                                                          │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé                                │09.11.95      

                                                                                          │25, 50 ìã                                                                 

                                                                                                                                                                    

│Ðåìèä [Àëëîïóðèíîë]                               │êñàíòèíîêñèäàçû èíãèáèòîð [M04AA01]     │òàáëåòêè 100 ìã               │Tad Pharmazeutisches Werk     │006274,       

                                                                                                                        │GmbH (Ãåðìàíèÿ)               │12.07.95      

                                                                                                                                                                    

│Ðåìèäîí {ïàðàöåòàìîë 0.2 ã, ìåòàìèçîë 0.2 ã,      │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 200 ìã/200 ìã/50 ìã  │Deva Holding AS (Òóðöèÿ)      │002858,       

│êîôåèí 50 ìã}                                     │ñðåäñòâî [N02BE51]                                                                                  │18.02.93      

                                                                                                                                                                    

│Ðåìîêñèêàì [Ïèðîêñèêàì]                           │ÍÏÂÑ [M02AA07]                          │êàïñóëû 10, 20 ìã             │Alkaloid (Ìàêåäîíèÿ)          │002604,       

                                                                                                                                                      │08.09.92      

                                                                                                                                                                    

│Ðåííè {ìàãíèÿ êàðáîíàò 80 ìã, êàëüöèÿ êàðáîíàò    │àíòàöèäíîå ñðåäñòâî [A02AF]             │òàáëåòêè æåâàòåëüíûå 80       │Laboratoires Roche-nicholas   │006873,       

│680 ìã}                                                                                   │ìã/680 ìã                     │SA (Ôðàíöèÿ)                  │04.12.95      

                                                                                                                                                                    

│Ðåíîð [Íîðôëîêñàöèí]                              │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Arobindo Pharma Ltd (Èíäèÿ)   │006342,        

                                                  │[J01MA06]                               │200, 400 ìã                                                 │02.08.95      

                                                                                                                                                                    

│Ðåíïðåññ [Ñïèðàïðèë]                              │ÀÊÔ áëîêàòîð [C09AA11]                  │òàáëåòêè 6 ìã                 │Sandoz Pharma Ltd (Øâåéöàðèÿ) │006680,        

                                                                                                                                                      │29.09.95      

                                                                                                                                                                    

│Ðåîìàêðîäåêñ {äåêñòðàí 40 50 ã, äåêñòðîçà 25 ã,   │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05AA05]     │ðàñòâîð äëÿ èíôóçèé           │Eczacibasi (Òóðöèÿ)           │01809, 18.04.90│

│íàòðèÿ õëîðèä 4.5 ã - 500 ìë}                                                                                                                                       

                                                                                                                                                                    

│Ðåîïèðèí {ôåíèëáóòàçîí 0.75 ã, àìèäàçîôåí 0.75 ã} │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │2111,         

                                                  │ñðåäñòâî [N02BB]                        │5 ìë                                                        │01.07.70,     

                                                                                                                                                      │22.05.84      

                                                                                                                                                                    

│Ðåîïèðèí {ôåíèëáóòàçîí 0.125 ã, àìèäàçîôåí 0.125  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │äðàæå                         │Gedeon Richter (Âåíãðèÿ)      │006595,       

│ã}                                                │ñðåäñòâî [N02BB]                                                                                    │20.11.95      

                                                                                                                                                                    

│Ðåïàðèë [Ýñöèí]                                   │àíãèîïðîòåêòîðíîå ñðåäñòâî [C05CX]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Dr.Madaus AG (ÔÐÃ)            │00402,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │14.09.76,     

                                                                                          │(àìïóëû) 5 ìã; äðàæå; ãåëü                                  │27.03.87      

                                                                                                                                                                    

│Ðåïàðèë-ãåëü Í [Ýñöèí]                            │àíãèîïðîòåêòîðíîå ñðåäñòâî [C05CX]      │ãåëü (òóáû)                   │Madaus AG (Ãåðìàíèÿ)          │005160,       

                                                                                                                                                      │20.07.94      

                                                                                                                                                                    

│Ðåòàáîëèë [Íàíäðîëîí]                             │àíàáîëè÷åñêîå ñòåðîèäíîå ñðåäñòâî       │ðàñòâîð äëÿ èíúåêöèé ìàñëÿíûé │Gedeon Richter (Âåíãðèÿ)      │2110,         

                                                  │[A14AB01]                               │(àìïóëû) 50 ìã - 1 ìë                                       │01.07.70,     

                                                                                                                                                      │22.05.84,     

                                                                                                                                                      │27.02.95      

                                                                                                                                                                    

│Ðåòàðïåí [Áåíçàòèí áåíçèëïåíèöèëëèí]              │àíòèáèîòèê, ïåíèöèëëèí [J01CE08]        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Biochemie GmbH (Àâñòðèÿ)      │003807,       

                                                                                          │ñóñïåíçèè äëÿ èíúåêöèé                                      │29.03.94      

                                                                                          │(ôëàêîíû) 1200000, 2400000 ÌÅ │                                            

                                                                                                                                                                    

│Ðåòàôèë [Òåîôèëëèí]                               │áðîíõîäèëàòèðóþùåå ñðåäñòâî [R03DA04]   │òàáëåòêè ïðîëîíãèðîâàííîãî    │Orion Pharmaceutica           │01448, 10.06.88│

                                                                                          │äåéñòâèÿ 200, 300 ìã          │(Ôèíëÿíäèÿ)                                 

                                                                                                                                                                    

│Ðåòèí À [Òðåòèíîèí]                               │ðåãåíåðàöèè ñòèìóëÿòîð [D10AD01]        │ëîñüîí 0.05%                  │Cilag-Chemie (Øâåéöàðèÿ)      │00499, 16.09.77│

                                                                                                                                                                    

│Ðåòèí-À [Òðåòèíîèí]                               │ðåãåíåðàöèè ñòèìóëÿòîð [D10AD01]        │êðåì 0.05%                    │Cilag (Øâåéöàðèÿ)             │006619,       

                                                                                                                                                      │11.01.96      

                                                                                                                                                                    

│Ðåòðîâèð [Çèäîâóäèí]                              │ïðîòèâîâèðóñíîå ñðåäñòâî [J05AB05]      │ðàñòâîð äëÿ âíóòðèâåííîãî     │Wellcome Foundation Ltd       │01413, 29.01.88│

                                                                                          │ââåäåíèÿ (ôëàêîíû) 200 ìã -   │(Âåëèêîáðèòàíèÿ)                            

                                                                                          │10 ìë; êàïñóëû 100, 250 ìã                                                

                                                                                                                                                                    

│Ðåòðîâèð [Çèäîâóäèí]                              │ïðîòèâîâèðóñíîå ñðåäñòâî [J05AB05]      │ñèðîï                         │Wellcome Foundation Ltd       │003588,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │14.12.93      

                                                                                                                                                                    

│Ðåóêàì [Ïèðîêñèêàì]                               │ÍÏÂÑ [M02AA07]                          │êàïñóëû 20 ìã                 │Laboratorio Pharmacheutica    │006843,       

                                                                                                                        │S.T. (Èòàëèÿ)                 │17.11.95      

                                                                                                                                                                    

│Ðåóìàôåí [Èáóïðîôåí]                              │ÍÏÂÑ [M02AA13]                          │òàáëåòêè 200, 400 ìã          │Beximco Pharmaceuticals Ltd   │003540,       

                                                                                                                        │(Áàíãëàäåø)                   │06.12.93      

                                                                                                                                                                    

│Ðåôëèí [Öåôàçîëèí]                                │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Ranbaxy Laboratories Ltd      │002846,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èíäèÿ)                       │15.02.93      

                                                                                          │(ôëàêîíû) 500, 1000 ìã                                                    

                                                                                                                                                                    

│Ðåöèïðî [Öèïðîôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Arobindo Pharma Ltd (Èíäèÿ)   │006343,       

                                                  │[J01MA02]                               │250, 500 ìã                                                 │02.08.95       

                                                                                                                                                                    

│Ðèàáàë [Ïðèôèíèé áðîìèä]                          │ì-õîëèíîáëîêàòîð [A03AB18]              │ðàñòâîð îðàëüíûé äëÿ äåòåé    │Laboratoires Jaques Logeais   │006688,       

                                                                                          │(ôëàêîíû) 250 ìã - 50 ìë      │(Ôðàíöèÿ)                     │10.10.95       

                                                                                                                                                                    

│Ðèáåêñ Ãîëà [Áåíçåòîíèÿ õëîðèä]                   │ïðîòèâîìèêðîáíîå ñðåäñòâî [R02AA09]     │ïàñòèëêè 1.5 ìã               │Prodotti Formenti Srl (Èòàëèÿ)│006687,       

                                                                                          │/ìåäîâî-ëèìîííûå/; ïàñòèëêè                                 │29.09.95      

                                                                                          │1.5 ìã /ìÿòíûå/; ïàñòèëêè 1                                               

                                                                                          │ìã /áàíàíîâûå/; ïàñòèëêè 1 ìã │                                            

                                                                                          │/àïåëüñèíîâûå/; ðàñòâîð äëÿ                                                

                                                                                          │ïîëîñêàíèÿ ðòà (ôëàêîíû)                                                  

                                                                                          │0.065% - 160 ìë                                                           

                                                                                                                                                                    

│Ðèâîëîêñ {àëãåëäðàò 3.49 ìã, ìàãíèÿ ãèäðîêñèä     │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Rivopharm SA (Øâåéöàðèÿ)      │006933,       

│3.99 ìã - 10 ìë}                                                                                                                                      │21.12.95      

                                                                                                                                                                    

│Ðèâîòðèë [Êëîíàçåïàì]                             │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AE01]    │òàáëåòêè 0.5, 2 ìã; êàïëè 2.5 │Hoffmann La Roche (Øâåéöàðèÿ) │00889, 01.12.81│

                                                                                          │ìã/ìë; ðàñòâîð äëÿ èíúåêöèé                                               

                                                                                          │(àìïóëû) 1 ìã - 2 ìë                                                      

                                                                                                                                                                    

│Ðèâòàãèë [Êëåìàñòèí]                              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 1 ìã                 │Rivopharm SA (Øâåéöàðèÿ)      │007536,       

                                                  │[R06AA04]                                                                                           │23.05.96      

                                                                                                                                                                    

│Ðèãåâèäîí {íîðãåñòðåë 0.15 ìã, ýòèíèëýñòðàäèîë    │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA06]      │òàáëåòêè                      │Gedeon Richter (Âåíãðèÿ)      │2692,         

│0.03 ìã}                                                                                                                                              │01.12.94,     

                                                                                                                                                      │26.02.82      

                                                                                                                                                                    

│Ðèä {ïèðåòðèí 0.3%, ïèïåðîíèë áóòîêñèä 3%}        │ïðîòèâîïåäèêóëåçíîå ñðåäñòâî [P03AC]    │øàìïóíü                       │Pfizer Overseas Inc (ÑØÀ)     │002863,       

                                                                                                                                                      │22.02.93      

                                                                                                                                                                    

│Ðèäàçèí [Òèîðèäàçèí]                              │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC02]     │òàáëåòêè 10, 25, 50, 100 ìã   │Al-Hikma Pharmaceuticals      │002599,       

                                                                                                                        │(Èîðäàíèÿ)                    │27.08.92      

                                                                                                                                                                    

│Ðèçàáåí [Òðàíèëàñò]                               │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │êàïñóëû                       │Kissei Pharmaceutical Co Ltd  │01373, 31.08.87│

                                                  │[R06A]                                                                │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ðèëêàïòîí [Êàïòîïðèë]                             │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │Medochemie Ltd (Êèïð)         │003634,       

                                                                                                                                                      │20.01.94      

                                                                                                                                                                    

│Ðèìàêòàí [Ðèôàìïèöèí]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã           │Ciba-Geigy (Øâåéöàðèÿ)        │00030,        

                                                                                                                                                      │11.02.70,     

                                                                                                                                                      │30.10.87      

                                                                                                                                                                    

│Ðèìàêòàí [Ðèôàìïèöèí]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã           │Ciba-Geigy Hindustan Ltd      │007683,       

                                                                                                                        │(Èíäèÿ)                       │24.07.96      

                                                                                                                                                                    

│Ðèìïèí [Ðèôàìïèöèí]                               │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300, 450 ìã      │Lyka Labs Ltd (Èíäèÿ)         │006421,       

                                                                                                                                                      │21.08.95      

                                                                                                                                                                    

│Ðèíã Í {àöåòèëñàëèöèëîâàÿ êèñëîòà 300 ìã, êîôåèí  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Heinrich Mack Nachf.          │005711,       

│50 ìã, àñêîðáèíîâàÿ êèñëîòà 25 ìã}                │ñðåäñòâî [N02BA51]                                                    │(Ãåðìàíèÿ)                    │02.02.95      

                                                                                                                                                                    

│Ðèíãåðà àöåòàò {íàòðèÿ õëîðèä 5.9 ã, íàòðèÿ       │ðåãèäðàòèðóþùåå ñðåäñòâî [B05BB01]      │ðàñòâîð äëÿ èíôóçèé (ìåøî÷êè  │Ilsanta (Ëèòâà)               │007664,       

│àöåòàò 4.15 ã, êàëüöèÿ õëîðèä 0.29 ã, êàëèÿ                                               │ïîëèïðîïèëåíîâûå) 250, 500,                                 │22.07.96      

│õëîðèä 0.3 ã, ìàãíèÿ õëîðèä 0.2 ã - 1 ë}                                                  │1000 ìë                                                                   

                                                                                                                                                                    

│Ðèíèë [Ôðàìèöåòèí]                                │àíòèáèîòèê, àìèíîãëèêîçèä [R01AX]       │êàïëè íàçàëüíûå (ôëàêîíû)     │Pierre Fabre (Ôðàíöèÿ)        │007582,       

                                                                                          │1.25 ã|100 ìë - 15 ìë                                       │13.06.96      

                                                                                                                                                                     

│Ðèíîïðîíò {êàðáèíîêñàìèí 4 ìã, ôåíèëýôðèí 20 ìã - │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │êàïñóëû 20 ìã; ñèðîï 100 ìë   │Mack (ÔÐÃ)                    │00764, 19.05.80│

│êàïñóëà; êàðáèíîêñàìèí 24 ìã, ôåíèëýôðèí 30 ìã -  │ïðîñòóäû [R05X]                                                                                                   

│1 ìë}                                                                                                                                                                

                                                                                                                                                                    

│Ðèíîñîë [Áåêëîìåòàçîí]                            │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │àýðîçîëü äîçèðîâàííûé 250     │Biospray N.G.Zikidis (Ãðåöèÿ) │007154,       

                                                  │ïðèìåíåíèÿ [R03BA01]                    │ìêã|äîçà (ôëàêîíû) 200 äîç                                  │19.03.96      

                                                                                                                                                                    

│Ðèíîôëóèìóöèë [Àöåòèëöèñòåèí]                     │îòõàðêèâàþùåå ñðåäñòâî [R05CB01]        │àýðîçîëü íàçàëüíûé            │Zambon Groupp Spa (Èòàëèÿ)    │005785,       

                                                                                          │äîçèðîâàííûé (ôëàêîíû ñ                                     │24.02.95      

                                                                                          │ðàñïûëèòåëåì) 25 ìë                                                       

                                                                                                                                                                    

│Ðèíòèä [Ðàíèòèäèí]                                │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150 ìã               │Kopran Ltd (Èíäèÿ)            │005527,       

                                                  │[A02BA02]                                                                                           │28.11.94      

                                                                                                                                                                    

│Ðèòàëìåêñ [Ìåêñèëåòèí]                            │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BB02]     │êàïñóëû 200 ìã                │Alkaloida (Âåíãðèÿ)           │005483,       

                                                                                                                                                      │14.11.94      

                                                                                                                                                                    

│Ðèòåð [Òåðôåíàäèí]                                │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 60, 120 ìã           │Panacea Biotec Ltd (Èíäèÿ)    │003975,       

                                                  │[R06AX12]                                                                                           │02.06.94      

                                                                                                                                                                    

│Ðèòåð [Òåðôåíàäèí]                                │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Panacea Biotec Ltd (Èíäèÿ)    │005555,       

                                                  │[R06AX12]                               │30 ìã|5 ìë                                                  │08.12.94      

                                                                                                                                                                    

│Ðèòìèëåí [Äèçîïèðàìèä]                            │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BA03]     │êàïñóëû 100 ìã                │Leiras (Ôèíëÿíäèÿ)            │006612,       

                                                                                                                                                      │21.12.95      

                                                                                                                                                                    

│Ðèòìîäàí [Äèçîïèðàìèä]                            │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BA03]     │êàïñóëû                       │Laboratoires Roussel (Ôðàíöèÿ)│00539, 30.12.77│

                                                                                                                                                                    

│Ðèòìîíîðì [Ïðîïàôåíîí]                            │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BC03]     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Knoll AG (ÔÐÃ)                │01233, 26.12.85│

                                                                                          │îáîëî÷êîé 150, 300 ìã                                                     

                                                                                                                                                                    

│Ðèòìîíîðì [Ïðîïàôåíîí]                            │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BC03]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Knoll AG (ÔÐÃ)                │002784,       

                                                                                          │70 ìã - 20 ìë                                               │29.12.92      

                                                                                                                                                                    

│Ðèòìîíîðì [Ïðîïàôåíîí]                            │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BC03]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Knoll AG (Ãåðìàíèÿ)           │006300,       

                                                                                          │10 ìã                                                       │18.07.95      

                                                                                                                                                                    

│Ðèôàäèí [Ðèôàìïèöèí]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã           │Lepetit Grouppe (Èòàëèÿ)      │00039,        

                                                                                                                                                      │11.11.84,     

                                                                                                                                                      │25.02.70      

                                                                                                                                                                    

│Ðèôàìîð [Ðèôàìïèöèí]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã           │Galenika (Þãîñëàâèÿ)          │00268,        

                                                                                                                                                      │10.01.74,     

                                                                                                                                                      │22.02.85      

                                                                                                                                                                    

│Ðèôàìïèí [Ðèôàìïèöèí]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã           │Ipca Laboratories Ltd (Èíäèÿ) │006950,       

                                                                                                                                                      │28.12.95      

                                                                                                                                                                    

│Ðèôàìïèí [Ðèôàìïèöèí]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã; òàáëåòêè │Yuhan Corporation (Êîðåÿ      │003233,       

                                                                                          │450, 600 ìã                   │Þæíàÿ)                        │16.08.93      

                                                                                                                                                                    

│Ðèôàìïèöèí [Ðèôàìïèöèí]                           │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã           │Sanavita Gesundcheitsmittel & │006756,       

                                                                                                                        │Co Kg (Ãåðìàíèÿ)              │27.10.95      

                                                                                                                                                                    

│Ðèôàìïèöèí [Ðèôàìïèöèí]                           │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 450 ìã                │Mesco Laboratories Ltd (Èíäèÿ)│002961,       

                                                                                                                                                      │12.04.93      

                                                                                                                                                                    

│Ðèôàìïèöèí [Ðèôàìïèöèí]                           │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300, 450 ìã      │Wave International (Èíäèÿ)    │007162,        

                                                                                                                                                      │21.03.96      

                                                                                                                                                                    

│Ðèôàðåí [Ðèôàìïèöèí]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã           │Remedica Ltd - Minnex (Êèïð)  │006806,        

                                                                                                                                                      │09.11.95      

                                                                                                                                                                    

│Ðèôàòåð {ðèôàìïèöèí, èçîíèàçèä, ïèðàçèíàìèä}      │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AM02] │òàáëåòêè                      │Marion Merrel Dow (Èòàëèÿ)    │005873,       

                                                                                                                                                      │30.03.95      

                                                                                                                                                                    

│Ðèôèíàã {ðèôàìïèöèí 150 ìã, èçîíèàçèä 100 ìã;     │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AM02] │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Marion Merrel Dow (Èòàëèÿ)    │005855,       

│ðèôàìïèöèí 300 ìã, èçîíèàçèä 100 ìã}                                                      │150, 300 ìã                                                 │15.03.95      

                                                                                                                                                                    

│Ðèôîãàë {ðèôàìïèöèí 125 ìã/250 ìã, àñêîðáèíîâàÿ   │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AM02] │ðàñòâîð äëÿ âíóòðèìûøå÷íûõ    │Galenika (Þãîñëàâèÿ)          │00118,        

│êèñëîòà 125 ìã/250 ìã, ëèäîêàèí 5 ìã/10 ìã -                                              │èíúåêöèé è ìåñòíîãî                                         │01.08.85,     

│àìïóëû im 1.5 ìë/3 ìë; ðèôàìïèöèí 0.5 ã,                                                  │ïðèìåíåíèÿ (àìïóëû) 125                                     │26.02.71      

│àñêîðáèíîâàÿ êèñëîòà 0.5 ã - àìïóëû iv}                                                   │ìã/1.5 ìë, 250 ìã/3 ìë;                                                   

                                                                                          │ðàñòâîð äëÿ âíóòðèâåííîãî                                                 

                                                                                          │ââåäåíèÿ (àìïóëû) 500 ìã - 10 │                                            

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ðèôîäåêñ [Ðèôàìïèöèí]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │êàïñóëû 150, 300 ìã; òàáëåòêè │Chung Kun Dah Corporation     │002624,       

                                                                                          │300, 450, 600 ìã              │(Êîðåÿ Þæíàÿ)                 │11.09.92      

                                                                                                                                                                    

│Ðîàêêóòàí [Èçîòðåòèíîèí]                          │ïðîòèâîñåáîðåéíîå ñðåäñòâî [D10BA01]    │êàïñóëû 10, 20 ìã             │Hoffmann La Roche (Øâåéöàðèÿ) │02003, 05.11.90│

                                                                                                                                                                    

│Ðîâàìèöèí [Ñïèðàìèöèí]                            │àíòèáèîòèê, ìàêðîëèä [J01FA02]          │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ     │Rhone-Poulenc Rorer (Ôðàíöèÿ) │007161,       

                                                                                          │îðàëüíîé ñóñïåíçèè äëÿ äåòåé                                │20.03.96      

                                                                                          │375000 ÌÅ, 750000 ÌÅ, 1.5 ìëí │                                            

                                                                                          │ÌÅ                                                                        

                                                                                                                                                                    

│Ðîâàìèöèí [Ñïèðàìèöèí]                            │àíòèáèîòèê, ìàêðîëèä [J01FA02]          │òàáëåòêè 1500000 ÌÅ, 3000000  │Rhone-Poulenc Rorer (Ôðàíöèÿ) │005544,       

                                                                                          │ÌÅ; ëèîôèëèç.ïîðîøîê äëÿ                                    │02.12.94      

                                                                                          │ïðèãîòîâëåíèÿ âíóòðèâåííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 1500000 ÌÅ │                                            

                                                                                                                                                                    

│Ðîãèïíîë [Ôëóíèòðàçåïàì]                          │ñíîòâîðíîå ñðåäñòâî [N05CD03]           │òàáëåòêè 1 ìã                 │Hoffmann La Roche (Øâåéöàðèÿ) │00752, 21.04.80│

                                                                                                                                                                    

│Ðîãèïíîë [Ôëóíèòðàçåïàì]                          │ñíîòâîðíîå ñðåäñòâî [N05CD03]           │òàáëåòêè 1 ìã; ðàñòâîð äëÿ    │Spofa (×åõîñëîâàêèÿ)          │2892, 06.05.88 │

                                                                                          │èíúåêöèé                                                                  

                                                                                                                                                                    

│Ðîêàëüòðîë [Êàëüöèòðèîë]                          │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │êàïñóëû 0.25, 0.5 ìêã         │Hoffmann La Roche (Øâåéöàðèÿ) │002321,       

                                                  │[A11CC04]                                                                                           │13.01.92      

                                                                                                                                                                    

│Ðîêæåëü [Àëãåëäðàò]                               │àíòàöèäíîå ñðåäñòâî [A02AB02]           │ñóñïåíçèÿ îðàëüíàÿ 8.08 ã     │Laboratories Roques (Ôðàíöèÿ) │007516,       

                                                                                          │(ïàêåòèêè) 11.6 ã                                           │15.05.96      

                                                                                                                                                                    

│Ðîêñàí [Ðîêñàòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 75, 150 ìã           │Hoechst AG (Ãåðìàíèÿ)         │005322,       

                                                  │[A02BA06]                                                                                           │12.09.94      

                                                                                                                                                                    

│Ðîêñèáèä [Ðîêñèòðîìèöèí]                          │àíòèáèîòèê, ìàêðîëèä [J01FA06]          │òàáëåòêè 150 ìã               │Cadila Laboratories Ltd       │003937,       

                                                                                                                        │(Èíäèÿ)                       │25.05.94      

                                                                                                                                                                    

│Ðîêñèêàì [Ïèðîêñèêàì]                             │ÍÏÂÑ [M02AA07]                          │òàáëåòêè 20 ìã                │Zdravle (Þãîñëàâèÿ)           │01122,        

                                                                                                                                                      │05.09.95,     

                                                                                                                                                      │10.12.84      

                                                                                                                                                                    

│Ðîêñèòåì [Ðîêñèòðîìèöèí]                          │àíòèáèîòèê, ìàêðîëèä [J01FA06]          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Kopran Ltd (Èíäèÿ)            │005207,       

                                                                                          │150 ìã                                                      │03.08.94      

                                                                                                                                                                     

│Ðîíàë [Àöåòèëñàëèöèëîâàÿ êèñëîòà]                 │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 500 ìã               │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003391,       

                                                                                                                                                      │08.10.93      

                                                                                                                                                                     

│Ðîíäîìèöèí [Ìåòàöèêëèí]                           │àíòèáèîòèê, òåòðàöèêëèí                 │êàïñóëû 300 ìã                │Alkaloid (Ìàêåäîíèÿ)          │00225,        

                                                  │ïîëóñèíòåòè÷åñêèé [J01AA05]                                                                         │06.10.72,     

                                                                                                                                                      │09.06.94,     

                                                                                                                                                      │13.12.83      

                                                                                                                                                                    

│Ðîíèàí [Íèôåäèïèí]                                │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã                 │Nippon Kayaku Co Ltd (ßïîíèÿ) │005156,       

                                                                                                                                                      │20.07.94      

                                                                                                                                                                    

│Ðîñöèëëèí [Àìïèöèëëèí]                            │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Ranbaxy Laboratories Ltd      │01003,        

                                                  │[J01CA01]                               │èíúåêöèîííîãî ðàñòâîðà        │(Èíäèÿ)                       │06.01.95,     

                                                                                          │(ôëàêîíû) 500 ìã                                            │11.04.83      

                                                                                                                                                                    

│Ðîôåðîí À [Èíòåðôåðîí àëüôà]                      │èììóíîñòèìóëÿòîð [L03AA04]              │ëèîôèëèç.ïîðîøîê äëÿ          │Hoffmann La Roche (Øâåéöàðèÿ) │002812,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │18.01.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 3000000,                                               

                                                                                          │9000000, 18000000 ÌÅ /â                                                   

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ðîöåôèí [Öåôòðèàêñîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA13]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Egis (Âåíãðèÿ)                │002521,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │19.06.92      

                                                                                          │(àìïóëû) 1 ã /â êîìïëåêòå ñ                                               

                                                                                          │ðàñòâîðèòåëåì/; ïîðîøîê äëÿ                                               

                                                                                          │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                                

                                                                                          │ðàñòâîðà (àìïóëû) 2 ã /â                                                  

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ðîöåôèí [Öåôòðèàêñîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA13]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Hoffmann La Roche (Øâåéöàðèÿ) │01167, 21.05.85│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 0.25, 0.5, 1, 2 ã                                               

                                                                                                                                                                    

│Ðóäîòåëü [Ìåäàçåïàì]                              │òðàíêâèëèçàòîð [N05BA03]                │òàáëåòêè                      │Oranienburger Pharmawerk GmbH │00410,        

                                                                                                                        │(ÔÐÃ)                         │08.07.92,     

                                                                                                                                                      │19.11.90      

                                                                                                                                                                    

│Ðóëèä [Ðîêñèòðîìèöèí]                             │àíòèáèîòèê, ìàêðîëèä [J01FA06]          │òàáëåòêè 150 ìã               │Roussel Uclaf (Ôðàíöèÿ)       │003217,       

                                                                                                                                                      │10.08.93      

                                                                                                                                                                    

│Ðóëèä [Ðîêñèòðîìèöèí]                             │àíòèáèîòèê, ìàêðîëèä [J01FA06]          │ôèëìòàáëåòêè 50, 100, 300 ìã  │Roussel Uclaf (Ôðàíöèÿ)       │006565,       

                                                                                                                                                      │28.09.95      

                                                                                                                                                                    

│Ðóìàëîí {ýêñòðàêò õðÿùåé òåëÿò, ýêñòðàêò ìîçãà    │ðåãåíåðàöèè ñòèìóëÿòîð [V03A]           │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Robapharm AG (Øâåéöàðèÿ)      │00049,        

│òåëÿò}                                                                                    │2.5 ìã/ìë                                                   │14.11.88,     

                                                                                                                                                      │15.07.70,     

                                                                                                                                                      │26.07.95      

                                                                                                                                                                    

│Ðóìàôåí ÑÐ [Äèêëîôåíàê]                           │ÍÏÂÑ [M01AB05]                          │êàïñóëû äëèòåëüíîãî           │Amoun Pharmaceutical          │005549,       

                                                                                          │âûñâîáîæäåíèÿ 100 ìã          │Industries Co, Apic (Åãèïåò)  │06.12.94      

                                                                                                                                                                    

│Ðýíêñ [Ðàíèòèäèí]                                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150, 300 ìã          │Unichem Laboratories Ltd      │005497,       

                                                  │[A02BA02]                                                             │(Èíäèÿ)                       │15.11.94      

                                                                                                                                                                    

│Ñàéçåí [Ñîìàòðîïèí]                               │ñîìàòîòðîïíûé ãîðìîí [H01AC01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratoires Serono SA        │002753,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Øâåéöàðèÿ)                   │15.12.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 4 ÌÅ /â                                                

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                                

                                                                                          │àìïóëû 1 ìë/                                                              

                                                                                                                                                                    

│Ñàéçåí [Ñîìàòðîïèí]                               │ñîìàòîòðîïíûé ãîðìîí [H01AC01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratoires Serono SA        │005783,        

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Øâåéöàðèÿ)                   │24.02.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 10 ÌÅ /â                                               

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                 

                                                                                                                                                                    

│Ñàéçåí [Ñîìàòðîïèí]                               │ñîìàòîòðîïíûé ãîðìîí [H01AC01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratoires Serono SA        │005968,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Øâåéöàðèÿ)                   │17.04.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 10 ÌÅ /â                                               

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ñàéòîòåê [Ìèçîïðîñòîë]                            │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîñòàãëàíäèí │òàáëåòêè                      │Searle (ÑØÀ)                  │01897, 05.07.90│

                                                  │[A02BB01]                                                                                                         

                                                                                                                                                                    

│Ñàëàìîë [Ñàëüáóòàìîë]                             │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │àýðîçîëü                      │Norton Healthcare Ltd         │003246,       

                                                  │[R03AC02]                                                             │(Âåëèêîáðèòàíèÿ)              │18.08.93      

                                                                                                                                                                    

│Ñàëîçèíàë [Ìåñàëàçèí]                             │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî [A07EC02]│òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Pro.Med.Cs (×åõèÿ)            │006069,       

                                                                                          │250 ìã                                                      │19.05.95      

                                                                                                                                                                    

│Ñàëîðèä [Íàòðèÿ õëîðèä]                           │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Beximco Infusions (Áàíãëàäåø) │005330,       

                                                                                                                                                      │19.09.94      

                                                                                                                                                                    

│Ñàëîðèí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]               │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 300 ìã               │M.J.Pharmaceuticals Ltd       │007042,       

                                                                                                                        │(Èíäèÿ)                       │02.02.96      

                                                                                                                                                                    

│Ñàëîôàëüê [Ìåñàëàçèí]                             │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî [A07EC02]│òàáëåòêè 250, 500 ìã; ñâå÷è   │Dr.Falk Pharma GmbH (Ãåðìàíèÿ)│005063,       

                                                                                          │250, 500 ìã; ñóñïåíçèÿ                                      │30.06.94      

                                                                                          │(êëèçìû) 4 ã/60 ã                                                         

                                                                                                                                                                    

│Ñàëîôàëüê [Ìåñàëàçèí]                             │ïðîòèâîìèêðîáíîå ñðåäñòâî [A07EC02]     │òàáëåòêè 250 ìã; ñâå÷è 250    │Zdravle (Þãîñëàâèÿ)           │002798,       

                                                                                          │ìã; ñóñïåíçèÿ ðåêòàëüíàÿ 4                                  │12.01.93      

                                                                                          │ã/60 ã                                                                    

                                                                                                                                                                    

│Ñàëüáóâåíò [Ñàëüáóòàìîë]                          │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 2 ìã, 4 ìã; àýðîçîëü │Leiras (Ôèíëÿíäèÿ)            │00596,        

                                                  │[R03AC02][R03CC02]                      │äëÿ èíãàëÿöèé 0.1 ìã|äîçà;                                  │16.06.93,     

                                                                                          │ìèêñòóðà 0.4 ìã/ìë                                          │19.06.78      

                                                                                                                                                                    

│Ñàëüáóòàìîë [Ñàëüáóòàìîë]                         │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 2 ìã                 │Indopharma (Èíäîíåçèÿ)        │003858,       

                                                  │[R03CC02]                                                                                           │18.04.94      

                                                                                                                                                                    

│Ñàëüáóòàìîë [Ñàëüáóòàìîë]                         │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │àýðîçîëü äîçèðîâàííûé 100     │Pharmchem International Ltd   │007467,       

                                                  │[R03AC02]                               │ìêã|äîçà (ôëàêîíû) 200 äîç    │(Âåëèêîáðèòàíèÿ)              │23.04.96      

                                                                                                                                                                    

│Ñàëüáóòàìîë [Ñàëüáóòàìîë]                         │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 2 ìã, 4 ìã           │Polfa (Ïîëüøà)                │2974, 06.06.90 │

                                                  │[R03CC02]                                                                                                         

                                                                                                                                                                    

│Ñàëüáóòàìîë [Ñàëüáóòàìîë]                         │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │àýðîçîëü (ôëàêîíû ñ           │Polfa, Poznanskie Zaklady     │007224,       

                                                  │[R03AC02]                               │äîçèðóþùèì êëàïàíîì) 10 ìë    │Farmaceutyczne SA (Ïîëüøà)    │24.06.96      

                                                                                                                                                                    

│Ñàëüáóòàìîë [Ñàëüáóòàìîë]                         │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 2, 4 ìã              │Remedica Ltd - Minnex (Êèïð)  │006803,       

                                                  │[R03CC02]                                                                                           │09.11.95      

                                                                                                                                                                    

│Ñàëüáóòàìîë [Ñàëüáóòàìîë]                         │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 2 ìã, 4 ìã           │Tamilnadu Dadha               │005261,       

                                                  │[R03CC02]                                                             │Pharmaceuticals Ltd (Èíäèÿ)   │22.08.94      

                                                                                                                                                                    

│Ñàëüáóòîë [Ñàëüáóòàìîë]                           │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 2 ìã; ñèðîï 2 ìã|5 ìë│Ilsan Iltash AS (Òóðöèÿ)      │003893,        

                                                  │[R03CC02]                                                                                           │04.05.94      

                                                                                                                                                                    

│Ñàëüìåòåð [Ñàëìåòåðîë]                            │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │àýðîçîëü 25 ìêã|äîçà          │Dr.Reddy's Laboratories Ltd   │006936,        

                                                  │[R03AC12]                                                             │(Èíäèÿ)                       │21.12.95      

                                                                                                                                                                    

│Ñàíàïðîêñ [Íàïðîêñåí]                             │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250, 500 ìã          │Sanofi-Winthrop               │006253,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │06.07.95      

                                                                                                                                                                    

│Ñàíãåçèê [Áóïðåíîðôèí]                            │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå ñðåäñòâî  │òàáëåòêè ñóáëèíãâàëüíûå 0.2   │Rusan Pharma (Èíäèÿ)          │005400,       

                                                  │[N02AE01]                               │ìã; ðàñòâîð äëÿ èíúåêöèé                                    │14.10.94      

                                                                                          │(àìïóëû) 0.3 ìã/1 ìë                                                      

                                                                                                                                                                    

│Ñàíäèììóí [Öèêëîñïîðèí]                           │èììóíîäåïðåññàíò [L04AA01]              │êàïñóëû æåëàòèíîâûå ìÿãêèå    │Sandoz Pharma (Øâåéöàðèÿ)     │002398,       

                                                                                          │25, 50, 100 ìã                                              │29.01.92      

                                                                                                                                                                    

│Ñàíäèììóí [Öèêëîñïîðèí]                           │èììóíîäåïðåññàíò [L04AA01]              │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Sandoz (Øâåéöàðèÿ)            │01187, 23.07.85│

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                                     

                                                                                          │(àìïóëû) 50 ìã/1 ìë, 250 ìã/5 │                                            

                                                                                          │ìë; ðàñòâîð îðàëüíûé                                                      

                                                                                          │(ôëàêîíû) 100 ìã/ìë           </